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ABSTRACT 
MODULATION OF L-TYPE CALCIUM CURRENT BY  
GABAB RECEPTOR ACTIVATION IN THE  
NEONATAL RAT HIPPOCAMPUS 
 
 
Jennifer G. Bray, B.S. 
 
Marquette University, 2010 
 
 
During the early postnatal period, the inhibitory neurotransmitter γ-aminobutyric 
acid (GABA) facilitates current through voltage-dependent L-type calcium channels by 
activating metabotropic GABAB receptors in the rat hippocampus.  In the present study, 
the effects of the GABAB receptor agonist baclofen on L-type currents were tested using 
whole-cell voltage clamp recording on neurons isolated from the superior region of 
hippocampi obtained from pups of various ages to determine the exact time course of L-
type current facilitation.  The facilitation of L-type current by GABAB receptors is more 
prominent during the second week of development. 
 
One developmental process that L-type current may be involved in is changes in 
the expression of the K+Cl- co-transporter (KCC2) and N+K+2Cl- co-transporter 
(NKCC1), which are necessary in the maturation of the GABAergic system. To 
investigate whether calcium influx through L-type channels and GABAB receptor 
activation affects the expression of chloride transporters during the early neonatal period, 
hippocampal cultures isolated from day 0 pups were treated with a GABAB agonist or an 
L-type channel antagonist for one week. Steady state KCC2 and NKCC1 levels were 
determined by Western blot analysis. Blockade of L-type channels drastically reduced 
KCC2 expression but not NKCC1 expression, suggesting that the upregulation of KCC2 
in the first postnatal week is dependent on calcium influx through L-type channels.   
 
The involvement of protein kinase C (PKC) and A (PKA) in the signaling 
pathway of L-type current modulation by GABAB receptors was also investigated using 
electrophysiological experiments.  The facilitatory response of baclofen was blocked in 
the presence of PKC inhibitors, but not PKA inhibitors.  Direct activation of PKC using a 
phorbol ester mimicked the facilitation of L-type current seen with baclofen, whereas 
facilitation was not seen with direct activation of PKA with a cAMP analogue.  Together, 
these experiments have demonstrated that the facilitation of L-type current by GABAB 
receptor activation is maximal during the second postnatal week in development and is 
mediated by PKC.  In addition, calcium influx through L-type channels also contributes 
to the maturation of the GABAergic system. 
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CHAPTER 1 
 
INTRODUCTION 
 
Understanding the function and regulation of voltage-dependent calcium channels 
(VDCC) is important because influx of calcium plays a fundamental role in the regulation 
of many cellular processes within the central nervous system (CNS).  Calcium influx is 
crucial for the propagation of some action potentials, changes in synaptic plasticity, the 
release of neurotransmitters, and for the expression of certain genes (for review see West 
et al., 2001; Catterall and Few, 2008; Neher and Sakaba, 2008; Gover et al., 2009).  
Calcium signaling is not only important in processes of mature neurons, but it also plays 
a critical role in the differentiation, growth, and maturation of developing neurons.  Due 
to the importance of calcium as an intracellular messenger, calcium channels are often 
regulated by neurotransmitters.  One of the most common neurotransmitters that has been 
shown to modulate several types of calcium channels is γ-aminobutyric acid (GABA).  
Many inhibitory interneuron subtypes within the hippocampus utilize GABA to regulate 
the overall excitability of the hippocampal region. 
Previous studies in the Mynlieff laboratory have shown modulation of calcium 
current by baclofen, a GABAB receptor agonist (Carter and Mynlieff, 2004).  In acutely 
cultured hippocampal neurons isolated from 1 week old neonatal rat pups, N-type 
calcium current decreases in response to activation of GABAB receptors.  In a subset of 
cells, L-type calcium current increases in response to activation of GABAB receptors.  
The facilitation of L-type current by GABAB receptors had not been previously observed 
in the mammalian nervous system.  Thus, this phenomenon became an area of particular 
interest in the laboratory.   
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The focus of my studies has been to investigate the phenomenon of L-type 
calcium current facilitation by GABAB receptor activation in the rat hippocampus, a 
phenomenon that has only been demonstrated in hippocampal cultures isolated from 
neonates.  The first goal of this project was to establish the exact time course of L-type 
calcium current facilitation by GABAB receptor activation during the first two weeks of 
development in the rat hippocampus.  In addition, the functional significance of L-type 
calcium current modulation on the expression levels of chloride transporters during 
development was investigated as well as the second messenger systems involved in L-
type calcium current modulation by GABAB receptors.  A better understanding of the 
importance of GABAB receptors in the development of a mature nervous system can be 
achieved by increasing our knowledge of GABAB receptor modulation of calcium 
channels.   
 
Voltage-Dependent Calcium Channels 
 
  Calcium channels have been classified into different subtypes according to 
voltage dependence, kinetics, pharmacology, and molecular biology.  VDCCs can be 
characterized by channel activation into two different subgroups, low voltage-activated 
(LVA) and high voltage-activated (HVA) channels (Carbone and Lux, 1984; Bean, 
1989a).  LVA channels are activated at low voltages and produce a transient current (T-
type channels; Nowycky et al., 1985; Bean and McDonough, 1998).  HVA channels have 
been further divided into 5 different subgroups (L-type, P-type, Q-type, N-type, and R-
type) based on pharmacology, kinetics, and molecular identification of the α1 subunit (for 
review see Tsien et al., 1988; Ertel et al., 2000; Lipscombe, 2004).   
 3
 
 
Experiments in the laboratory have primarily focused on L-type calcium channels, 
which are found in neurons and different muscle types.  Neuronal voltage-dependent L-
type calcium channels are heteromeric complexes that contain an α1 pore forming 
subunit, and several auxiliary subunits including an extracellular α2 subunit, an 
intracellular β subunit, and a transmembrane δ subunit (Figure 1.1; for review see  
 
Figure 1.1: Structure of neuronal L-type calcium 
channels.  The channel is made up of four subunits.  
The α1 subunit forms the channel pore.  The α2δ 
subunit associates with the α1 subunit to modulate 
current amplitude.  The intracellular β subunit 
regulates the activation, inactivation, current, and 
voltage dependence of the α1 subunit (Singer et al., 
1991).   
 
Catterall, 1998, 2000).  The α2δ and β auxiliary subunits modulate the trafficking and 
control the function of the α1 subunit (Singer et al., 1991).  The α1subunit is made up of 4 
domains with each domain containing six transmembrane spanning segments (Figure 1.2; 
Catterall, 2000).  Due to its role as the conduction pore, gating apparatus, and voltage  
 
Figure 1.2: Structure of the α1 subunit of VDCCs.  The amino acid sequence for the α1 subunit is 
approximately 2000 residues long and is organized in four repeated domains, each of which 
contain 6 transmembrane segments (S1 – S6).  The S4 transmembrane segment contains several 
positively charged amino acids and is thought to be the voltage sensor.  The N- and C- termini are 
cytoplasmic. The cytoplasmic regions are key sites for phosphorylation by kinases. Figure 
obtained from Tedford and Zamponi, 2006.  
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sensor, the α1 subunit is a major site of regulation by drugs, toxins, and phosphorylation 
by protein kinase C (PKC), protein kinase A (PKA), and Ca2+/calmodulin-dependent 
protein kinase II (CaMKII; for review see Catterall 1998, 2000).  
 
Table 1: Summary of the identification and nomenclature of VDCCs. To distinguish between the 
various types of calcium channels different channels blockers can be used (Adapted from Ertel et 
al., 2000). 
 
Currently, ten pore-forming α1 subunits have been cloned and are used to further 
classify calcium channels into 3 different families Cav1, Cav2, and Cav3 (Table 1; Ertel et 
al., 2000; Lipscombe et al., 2004).  The Cav1 family of α1 subunits consists of several 
subtypes of L-type calcium channels, which produce long lasting calcium currents.  
These types of channels have relatively slow activation and inactivation kinetics, with 
some subtypes demonstrating calcium-dependent inactivation along with voltage-
dependent inactivation (for review see Lipscombe et al., 2004).  Cav1.1 channels are 
found in skeletal muscle where they are linked to ryanodine receptors in the sarcoplasmic 
reticulum.  Cav1.2 channels are found in cardiac and smooth muscle where they initiate 
muscle contraction, in neurons where they are involved in gene regulation, and in 
endocrine cells where they aid in secretion (for review see McDonald et al., 1994; 
Catterall, 2000; Lipscombe et al., 2004).  Cav1.3 channels have similar expression as Cav 
1.2 channels and are expressed in neurons, cardiac muscle, and endocrine cells.  Cav1.4 
L-type calcium channels are located in retinal tissue and are linked to phototransduction 
(Baumann et al., 2004).  Cav1.2 and Cav1.3 L-type calcium channels are both located on 
Functional Identification Molecular Identification Pharmacological Antagonists 
 HVA L-type Cav 1.1, 1.2,1.3, 1.4 Dihydropyridines 
HVA P/Q-type Cav 2.1 ω-Agatoxin IVA 
HVA N-type Cav 2.2 ω-Conotoxin GVIA 
HVA R-type Cav 2.3 Nickel, SNX-483 
LVA T-type Cav 3.1,3.2,3.3 Nickel, amiloride 
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the soma and dendrites of neurons (Westenbroek et al., 1990; Budde et al., 1998; McRory 
et al., 2004).  These neuronal types of L-type calcium channels are modulated by protein 
phosphorylation and regulate a number of processes such as activity-dependent gene 
expression, mRNA stability, neuronal survival, synaptic efficacy, and the activity of 
neighboring ion channels (Murphy et al., 1991; Bading et al., 1993; Christie et al., 1995; 
Finkbeiner and Greenberg, 1998; Hardingham et al., 1998; Marrion and Tavalin, 1998; 
Charles et al., 1999; Schorge et al., 1999; Dolmetsch et al., 2001; Marshall et al., 2003; 
for review see Lipscombe, 2004; Pinato et al, 2009).   
The Cav2 family consists of N-type, P/Q-type, and R-type calcium channels.  
These channels are most commonly found in neurons and regulate the release of 
neurotransmitters within synapses.  T-type calcium channels make up the Cav3 family of 
α1 subunits.  T-type calcium channels, which can be found in the brain, heart, kidney, and 
liver play an important role in regulating overall cell excitability and hormone secretion 
(for review see Cueni et al., 2009; Iftinca and Zamponi, 2009).  The HVA Cav1 and Cav2 
calcium channels are primarily distinguished from one another in native neurons through 
pharmacological methods.  L-type calcium channels are sensitive to dihydropyridines 
(DHP), whereas P/Q-type calcium channels are blocked by varying concentrations of a 
spider venom toxin ω-agatoxin IVA.  N-type calcium channels are blocked by the cone-
snail toxin ω-conotoxin GVIA and can not be blocked by DHP antagonists or activated 
by DHP agonists (Table 1; Fox, 1987; Cruz et al., 1987; Tsien et al., 1988; Bean, 1991; 
Mintz et al., 1992).   
The use of heterologous expression systems to study calcium channel properties 
has given a wealth of information characterizing the different calcium channel subtypes.  
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When Cav1.1 L-type calcium channels were expressed in muscle cells from dysgenic 
mice, the currents were small and demonstrated slow activation kinetics (Tanabe et al., 
1988; Adams et al., 1990).  In comparison, when Cav1.2 L-type calcium channels were 
expressed, the activation kinetics were faster than seen with the Cav1.1 (Tanabe et al., 
1990).  Further heterologous expression studies have demonstrated different activation 
thresholds between Cav1.2 and Cav1.3 L-type calcium channels, with Cav1.3 channels 
exhibiting a lower activation threshold than Cav1.2 channels (Safa et al., 2001; Scholze et 
al., 2001; Xu and Lipscombe, 2001).  Cav1.3 channels begin to activate at potentials 
around -55 mV, whereas Cav1.2 channels begin to activate closer to -30 mV.   This 
suggests that Cav1.3 channels, but not Cav1.2 channels, may activate at subthreshold 
depolarizations.  The differences in activation suggest that Cav1.3 and Cav1.2 may 
function in different signaling pathways within neurons.  Calcium channels belonging to 
the Cav2 family can be distinguished from L-type calcium channels, because they require 
stronger depolarizations for activation (positive to -20 mV) and demonstrate moderate 
voltage-dependent inactivation (Tsien et al., 1988; Fujita et al., 1993; Delcour et al., 
1993). 
 
The Hippocampus 
The hippocampus is a region of the brain that plays a prominent role in spatial 
learning and in the formation and retrieval of memories (for review see Bird and Burgess, 
2008; Neves et al., 2008; Cutsuridis and Wennekers, 2009; Eichenbaum and Fortin, 
2009).   The hippocampus is also involved in the formation and spread of seizures 
(Falconer et al., 1964; Dam, 1980, 1982; Schwartzkroin, 1994).  As a result of seizure 
 7
 
 
activity, several structural and functional changes occur in the neuronal connectivity of 
the hippocampus (for review see Lado et al., 2002; Naegele, 2009).  This hippocampal 
damage can lead to recurrent seizures and ultimately may result in the development of 
epilepsy (Sutula et al., 1989; Overstreet-Wadiche et al., 2006).   
As one of the most studied brain regions, the cell types of the hippocampus and 
their network connections have been characterized relatively well.  The hippocampus is a 
highly organized structure that is divided into three major regions called the dentate 
gyrus, the CA3, and the CA1.  The hippocampus acts as a unidirectional circuit that 
allows information to flow into, through, and then out to other neurons throughout the 
brain (Andersen et al., 1973).  There are three major excitatory synaptic connections 
within the hippocampus (Figure 1.3).  The main input into the hippocampus is through 
the perforant pathway in which axons from the entorhinal cortex project onto granule 
cells in the dentate gyrus.  The mossy fiber pathway extends from granule cell axons that 
synapse onto pyramidal cells within the CA3 region.  The Schaffer collateral pathway 
consists of axons from the CA3 pyramidal cells that project onto pyramidal cells within 
the CA1 region.  The principle output from the hippocampus occurs through CA1 axons, 
which project to the subiculum and back to the entorhinal cortex (Amaral, 1993; Braak et 
al., 1996). 
 
Figure 1.3: The Hippocampal Network. 
Input from the entorhinal cortex forms 
connections with the dentate gyrus (DG) 
through the perforant path.  Granule cell 
axons in the dentate gyrus project to the 
CA3, which in turn projects to the CA1 
through the Schaffer collateral pathway. 
 
DG
CA3
CA1
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The overall excitability of the adult hippocampus is regulated by local inhibitory 
interneurons, which control the number of active pyramidal cells and their firing pattern 
by releasing the inhibitory neurotransmitter GABA.  Pyramidal cells are modulated by a 
diverse population of GABAergic interneurons.  There are over 21 distinguishable 
inhibitory interneurons that synapse either on specific regions of CA1 pyramidal cells or 
onto other interneurons (for review see Somogyi and Klausberger, 2005; Ascoli et al., 
2008; Klausberger and Somogyi, 2008; Cutsuridis and Wennekers, 2009; Klausberger, 
2009).  These interneurons are classified based on their anatomical, morphological, and 
physiological characteristics along with antibody staining.  Although the importance of 
interneurons in hippocampal functioning is clear, very little is known about the 
mechanisms involved in the maturation of inhibitory interneurons and synapses within 
the hippocampus.  The experiments described here contribute to our knowledge of 
hippocampal development by investigating GABAB receptor facilitation of L-type 
calcium current during the maturation of the GABAergic circuitry within the neonatal rat 
hippocampus.   
The hippocampus appears to be involved in severe illnesses such as 
schizophrenia, depression, bipolar disorder, and epilepsy.  Seizures are more likely to 
occur in immature humans and animals, and in humans seizure susceptibility peaks 
during the first few months after birth (Sperber, 1999; for review see Lado et al., 2002; 
Holopainen, 2008; Rakhade and Jensen, 2009).  This is most likely due to the fact that the 
inhibitory GABAergic system within the hippocampus is not yet fully developed and thus 
neurons are highly excitable due to the lack of inhibition.  In addition, at least in rat 
hippocampus, the response to GABA is excitatory during the first few postnatal weeks.  
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Therefore, it is essential to understand the time course and mechanisms involved in the 
development of the hippocampus and the GABAergic system to aid in the treatment of 
early onset seizures.   
 
GABA Receptors 
 
The importance of calcium influx in neuronal function makes calcium channels a 
prime site for neurotransmitter modulation.  One neurotransmitter within the mammalian 
CNS that can regulate calcium channels is GABA.  GABA is the major inhibitory 
neurotransmitter in the mammalian CNS.  It acts by binding to specific receptors, which 
produces a variety of cellular effects in both presynaptic and postsynaptic neurons. 
GABA receptors have been classified into 3 different subtypes, GABAA, GABAB, and 
GABAC.  The ionotropic GABAA and GABAC receptors have an ion channel 
incorporated into the receptor and mediate fast inhibitory synaptic transmission (Figure 
1.4).  When GABA binds to the receptor it causes a conformational change that allows 
chloride ions to flow through the channel causing the cell to hyperpolarize, which 
prevents it from reaching threshold.  GABAB receptors are metabotropic and mediate 
their effects through G-proteins (Figure 1.4).  Compared to the ligand-gated GABAA and 
GABAC channels, the effects of GABAB receptor activation are slower and often involve 
the regulation of calcium or potassium channels.   
GABAB receptors are expressed on neurons both presynaptically, where they 
modulate neurotransmitter release and postsynaptically, where they modulate neuronal 
excitability.  Functional GABAB receptors are heterodimeric complexes of two 
homologous subunits, GABAB1 and GABAB2 (Kaupmann et al., 1997, 1998; Jones et al., 
1998; White et al., 1998; Kuner et al., 1999; Ng et al., 1999; White et al., 2002). 
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Figure 1.4: GABA Receptors.  GABAA and GABAC receptors are ionotropic and form a channel 
that is permeable to chloride ions.  GABAA receptors are pentameric structures that can be 
assembled from a number of different subunits (α, β, γ, δ, and ρ).  The most common GABAA 
receptor found in the brain is composed of 2α:2β:1γ.  GABAC receptors, which are constructed 
from ρ subunits, are insensitive to bicuculline and are found only in the retina.  GABAB receptors 
are heterodimers, consisting of GABAB1 and GABAB2 subunits.  GABAB receptors are 
metabotropic and are coupled to G-proteins and often regulate K+ and Ca2+ channels.   
 
There are two different isoforms of the GABAB1 subunit, GABAB1a and GABAB1b.  
These two isoforms are differentially localized within the hippocampus where GABAB1a 
is located presynaptically, while GABAB1b is primarily located postsynaptically (Vigot et 
al., 2006).  In order for GABAB receptors to be functional, the GABAB1 and the GABAB2 
subunits must form a dimer and be inserted into the membrane.  It is thought that G-
protein coupled receptors (GPCRs) form dimers to increase their surface area so that it is 
possible to interact with trimeric G-protein complexes (Bouvier, 2001; Hamm, 2001).  To 
ensure that the complexes are assembled properly before being inserted into the 
membrane, GABAB receptors must first pass a dimerization-dependent trafficking 
checkpoint (Margeta-Mitrovic et al., 2000; Pagano et al., 2001).  Once functional 
heterodimeric GABAB receptors are inserted into the plasma membrane, agonists are able 
to bind to the ligand binding domain located on the large extracellular N-terminus of the 
GABAB1 subunit (Galvez et al., 1999; 2000a; 2000b).  Ligand binding causes a 
conformational change in the GABAB2 subunit, which results in G-protein coupling and 
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activation.  Subsequently, activated G-proteins are able to modulate downstream 
signaling pathways (Figure 1.5).  
 
Figure 1.5:  Structure of GABAB receptors.  GABAB1 and GABAB2 heterodimers 
are trafficked and inserted into the plasma membrane.  Activation of GABAB1 by 
GABA binding to the N-terminus results in a conformational change in the 
GABAB2 subunit, which allows recruitment and activation of G-proteins. Figure 
obtained from Enna, 2001.  
 
 
GABAB receptors are commonly coupled to Gαi and Gαo proteins (Asano and 
Ogasawara, 1986; Morishita et al., 1990; Campbell et al., 1993; Menon-Johansson et al., 
1993; Greif et al., 2000; Bettler et al., 2004).  Modulation of ion channels and other 
downstream effectors can either occur via the α subunit or βγ subunits.  Inhibition of N-
type and P/Q-type calcium current by presynaptic GABAB receptor activation occurs 
through the Gβγ subunits that are associated with Gαi and Gαo proteins (Scholz and 
Miller, 1990; Menon-Johansson et al., 1993; Mintz and Bean, 1993; Pfrieger et al., 1994; 
Amico et al., 1995; Cardozo and Bean, 1995; Poncer et al., 1997; Kajikawa et al., 2001; 
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for review see Bettler et al., 2004).  Inhibition of N-type and P/Q-type calcium channels 
in the presynaptic terminal following GABAB receptor activation will ultimately lead to a 
decrease in neurotransmitter release (Hirata et al., 1995; Doze et al., 1995; Takahashi et 
al., 1998).  Postsynaptic GABAB receptor activation of inwardly rectifying K+ current 
occurs through the Gβγ subunits that are associated with Gαi and Gαo proteins and results 
in the hyperpolarization of the postsynaptic cell (Gähwiler and Brown, 1985; Lüscher et 
al., 1997; Kaupmann et al., 1998; Yamada et al., 1998; for review see Bettler et al., 
2004).   
Using GABAB receptor knockout mice, it has been demonstrated that GABAB 
receptors are critically involved in neuronal development.  GABAB receptor mutations or 
loss of functional GABAB receptors can lead to a number of abnormalities during 
development.  In the absence of functional GABAB1 subunits (site of GABA binding) 
neuronal excitability is not under control and mice exhibit epilepsy by postnatal week 2, 
hyperalgesia, hyperlocomotor activity, and have an impaired memory (Prosser et al., 
2001; Schuler et al., 2001).  The mean average life expectancy of GABAB1 knockout 
mice is 21 days (Prosser et al., 2001).  Mice that lack GABAB2 subunits have similar 
symptoms as mice lacking GABAB1 subunits, which is consistent with the heterodimeric 
structure of GABAB receptors (Gassmann et al., 2004; Mombereau et al., 2005).  In 
comparison to the severe deficits seen in GABAB1 or GABAB2 knockout mice, adult 
animals treated with acute or chronic GABAB receptor antagonists do not develop such 
extreme behavioral changes (Bittiger et al., 1993; Mondadori et al., 1993; Vergnes et al., 
1997).  Although it is hard to get complete blockage of GABAB receptors in vivo, these 
experiments are suggestive that GABAB receptors may be critically involved in the 
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development of a mature nervous system.  Therefore, it is essential to understand the role 
that GABAB receptors play in the development of neurons particularly within the 
hippocampus, where several of the behavioral deficits seen in the GABAB1 and GABAB2 
knockout mice arise.   
 
GABA Function During Development 
 
It is well documented that GABA exerts an excitatory rather than inhibitory 
response early in neuronal development due to the high concentration of intracellular 
chloride ions (Mueller et al., 1984; Ben-Ari et al., 1989; Cherubini et al., 1991; Luhmann 
and Prince, 1991; Gaiarsa et al., 1995; Owens et al., 1999).  During neuronal maturation 
GABAA receptor activation depolarizes the membrane.  This GABA-induced 
depolarization shifts to a hyperpolarizing effect in the first few postnatal weeks due to a 
change in the reversal potential of chloride (Cherubini et al., 1990; Luhmann and Prince, 
1991; Chen et al., 1996; Owens et al., 1999).  The developmental switch of the 
GABAergic system has been demonstrated in both cultured hippocampal neurons as well 
as in hippocampal slices (Rivera et al., 1999; Ganguly et al., 2001).  It is believed that the 
upregulation of the K+Cl- co-transporter, KCC2, and the downregulation of the, N+K+2Cl- 
co-transporter, NKCC1, may be responsible for shifting the chloride reversal potential in 
immature neurons (Plotkin et al., 1997; Lu et al., 1999; Rivera et al., 1999; Vu et al., 
2000; Hübner et al., 2001a).  NKCC1 expression predominates in immature neurons and 
mediates chloride influx, while KCC2 expression predominates in mature neurons and 
mediates chloride efflux (Figure 1.6; for review see Delpire, 2000; Payne et al., 2003).   
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Figure 1.6:  Maturation of the GABAergic system. In immature neurons the intracellular chloride 
concentration is kept relatively high due to the expression of NKCC1, which pumps chloride into 
the cell.  GABAA receptor activation results in an efflux of chloride and excites the cell.  In 
comparison, KCC2 expression predominates in mature neurons and mediates chloride efflux.  
GABAA receptor activation results in an influx of chloride and inhibits adult neurons.  Figure 
adapted with permission from Fukuda et al., 1998.  Abbreviations: KCC2, K+ Cl- co-transporter; 
NKCC1, Na+ K+ 2Cl- co-transporter; ClC2, voltage-dependent chloride channel; L-channel, 
voltage-dependent L-type calcium channel. 
 
There are nine types of cation chloride transporters (CCCs) found in mammals.  
There are two NKCCs (NKCC1 and NKCC2), four KCCs (KCC1-4), one Na+Cl- (NCC), 
and two additional CCCs (ClP1 and CCC9; for review see Delpire, 2000; Blaesse et al., 
2009).  NCC and NKCC2 are renal specific (for review see Knepper and Brooks, 2001; 
Castrop and Schnermann, 2008), whereas KCC2 is neuron specific (Payne et al., 1996; 
Lu et al. 1999).  NKCC1 is expressed in neurons and also glial cells within the CNS 
(Kanaka et al., 2001; Hübner et al., 2001b). The three other types of KCCs (KCC1, 
KCC3, and KCC4) are expressed in various tissues including neurons, muscle, and the 
kidney (for review see Payne et al., 2003; Blaesse et al., 2009).  CCC activity can be 
 15
 
 
regulated through phosphorylation by kinases.  For example, NKCC1 activation occurs 
through phosphorylation of a regulatory domain in its N-terminus (Darman and Forbush, 
2002; Flemmer et al., 2002).  The two predominant CCCs within hippocampal neurons 
are KCC2 and NKCC1, however their expression levels are developmentally regulated 
during the first few postnatal weeks.   
Due to the high intracellular chloride concentration in immature neurons, the 
activation of GABAA receptors causes an efflux of chloride, which depolarizes the cell.  
If sufficiently depolarized VDCCs will be activated leading to an increase of L-type 
calcium current.  Using calcium imaging, Gangluy and others (2001) investigated the 
developmental timecourse of GABA-induced increases in intracellular calcium levels in 
hippocampal cultures isolated from E18 rats.  In hippocampal neurons allowed to remain 
in culture for 4 to 9 days, increases in [Ca2+]i were observed with GABA application.  
The increase in [Ca2+]i was blocked with GABAA antagonists and L-type calcium channel 
blockers.  These data demonstrate that GABAA receptor activation can lead to influx of 
calcium through L-type calcium channels during the early neonatal period.  The 
facilitation of L-type calcium current could further increase calcium influx in response to 
GABA in a subset of cells.   
The change in chloride transporter expression decreases the internal chloride 
concentration by increasing the extrusion of chloride, which results in a change of the 
reversal potential of GABAA mediated current (Ben-Ari et al., 1989; Leinekugel et al., 
1995, 1997, 1998; Khazipov et al., 1997).  It has been well documented that the 
upregulation of KCC2 transporter levels play a role in changing the chloride reversal 
potential (Payne, 1997; Lu et al., 1999; Rivera et al., 1999; Ganguly et al., 2001).  Rivera 
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and others (1999) demonstrated that inhibition of KCC2 expression with antisense 
oligodeoxynucleotides delayed the shift in the reversal potential of GABAA responses 
from depolarizing-to-hyperpolarizing in cultured neonatal rat hippocampal slices.   They 
demonstrated that in cultured hippocampal slices isolated from postnatal 0 to 4 day old 
rats, GABAA receptor activation evoked depolarizing responses, whereas in hippocampal 
slices isolated from postnatal rats 13 to 30 days old GABAA receptor activation evoked 
hyperpolarizing responses.  When KCC2 expression levels were inhibited with antisense 
oligonucleotides in slices from postnatal 11 to 13 day old rats, the driving force of 
GABAA demonstrated a significant positive shift when compared to control slices 
(Rivera et al., 1999).   These data demonstrate that KCC2 expression is involved in the 
fast hyperpolarizing GABAA receptor responses in mature hippocampal neurons.   
In addition to the upregulation of KCC2, the downregualtion of NKCC1 
expression may also play a role in changing the chloride reversal potential (Plotkin et al., 
1997; Wang et al., 2002).  However, there are several conflicting results when looking at 
NKCC1 mRNA levels within the developing rat hippocampus.  Using in situ 
hybridization, Plotkin et al. (1997) reported that NKCC1 mRNA expression levels peak 
in the hippocampus of rats at postnatal day 7.  In comparison, Wang et al. (2002) who 
also performed in situ hybridization reported higher NKCC1 mRNA levels in the 
hippocampus of postnatal day 15 rats through postnatal day 40 rats.  Most of the studies 
on KCC2 and NKCC1 expression have measured mRNA levels.  In theory, changes in 
mRNA levels should lead to changes in protein.  However, mature protein levels are not 
only dependent on translation of mRNA, but also on the degradation of the protein.  In 
the current study, protein levels of KCC2 and NKCC1 were measured rather than mRNA 
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levels since ultimately it is the protein that is the end product.  Therefore, the 
developmental changes of NKCC1 and KCC2 protein levels within the developing rat 
hippocampus were further characterized.  
It has been demonstrated that GABA may be responsible for the depolarizing-to-
hyperpolarizing switch and that calcium influx is necessary for this GABAA mediated 
switch (Ganguly et al., 2001).  Ganguly et al. (2001) showed that application of GABAA 
antagonists delayed the excitatory to inhibitory switch and also delayed the increase in 
KCC2 mRNA expression levels in cultured hippocampal neurons.  In addition, chronic 
blockade of L-type calcium channels with the L-type channel antagonist nimodipine 
significantly delayed the developmental change in the GABAA reversal potential.  These 
two observations taken together suggest that GABAA receptors directly depolarize the 
membrane to open L-type calcium channels and that influx of calcium is involved in the 
developmental maturation.  Ganguly et al. (2001) did not directly look at the effects of L-
type calcium current on KCC2 transporter protein levels.  Calcium influx across L-type 
calcium channels may regulate the changes in chloride transporter expression.  Therefore, 
the enhancement of L-type calcium current by GABAB receptor activation demonstrated 
by Carter and Mynlieff (2004) may play a role in increasing intracellular calcium levels 
that mediate the switch of GABAA responses from excitatory to inhibitory effects.  The 
goal of the present study was to increase our knowledge of GABAB receptors and their 
downstream modulation to gain a better understanding of their functional role in the 
development of a mature CNS.   
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G-proteins 
 GABAB receptors are coupled to guanine nucleotide-binding proteins, also known 
as G-proteins.  G-proteins linked to GPCRs are heterotrimeric proteins consisting of an α, 
β, and γ subunit.  GPCRs belong to a family of seven transmembrane spanning receptors 
and are activated by a variety of extracellular neurotransmitters and hormones.  When 
activated by ligands or agonists, GPCRs interact with G-proteins, which stimulate the 
exchange of GDP on the Gα subunit for cytoplasmic GTP.  Following nucleotide 
exchange, the Gα subunit dissociates from the Gβγ subunits which remain anchored to 
the plasma membrane.  Both the free Gα-GTP bound subunit as well as the Gβγ subunit 
complex are biologically active and can modulate downstream effector systems.  The 
intrinsic GTPase activity of the α subunit converts GTP to GDP + Pi, which promotes the 
reassociation of the inactive Gα-GDP to the Gβγ complex (for review see McCudden et 
al., 2005; Wettschureck and Offermanns, 2005).  
 Gα subunits are classified into four groups based on their sequence similarity and 
activation of various cell signaling systems (Table 2).  Each family consists of several 
different types of α-subunits, some of which show very specific expression patterns (for 
review see McCudden et al., 2005; Wettschureck and Offermanns, 2005).  Gαs proteins 
activate adenylyl cyclase and are activated by cholera toxin-mediated ADP ribosylation, 
whereas the Gαi/o proteins inhibit adenylyl cyclase activity and are inhibited by pertussis 
toxin (PTX) mediated ADP ribosylation (Fields and Casey, 1997).  Gαt, also known as 
transducin, is found in cells of the retina and is coupled to the GPCR, rhodopsin.  The G-
protein that is primarily found in taste cells is called Gαgust or gustducin.  Gαq/11 proteins 
activate phospholipase C (PLC) and are not affected by either cholera toxin or PTX.  
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Gα12/13 results in the activation of a small GTPase RhoA, which is overexpressed in 
various tumor cell types (Fritz et al., 1999; Abraham et al., 2001; Kamai et al., 2001; 
Fritz et al., 2002).   
G-Protein 
Subfamily Gα Location Pharmacology 
Potential Effector 
Proteins 
Gαs 
 
αs 
αolf 
Ubiquitous 
Olfactory     
Epithelium 
Cholera Toxin Activates Adenylyl Cyclase 
Gαi/o 
αi1, αi2, αi3 
αo 
αz 
αt-r 
αt-c 
αgust 
 
Ubiquitous 
Neuronal 
Neuronal 
Retinal Rods 
Retinal Cones 
Taste Buds 
 
Pertussis 
Toxin 
Inhibits Adenylyl Cyclase, 
activates K+ channels, 
 inhibits Ca++ Channels, 
increases 
phosphodiesterase 6 
activity (rods and cones) 
Gαq 
αq, α11 
α14 
α15/16 
Ubiquitous 
Kidney, Lung 
Hematopoietic 
cells 
Ym-254890 
Activates  
Phosphlipase Cβ1-4 
 
Gα12/13 
α12, α13 Ubiquitous 
  
Activates Small G-
proteins, RhoA, and Heat 
Shock Protein  
Table 2: Pharmacology and signaling properties of the major G-protein subunit types.  (Table 
adapted from Wettschureck and Offermanns, 2005; Tedford and Zamponi, 2006).   
 
Following dissociation of Gα-GTP, the Gβγ subunit can activate a large number 
of effectors, including G-protein-regulated inward-rectifier K+ channels (GIRK 
channels), PLCβ, and adenylyl cyclase (Camps et al., 1992; Smrcka and Sternweis, 1993; 
Park et al., 1993; Pian and Dobbs, 1995; Yamada et al., 1998).  Due to the several 
different types of G-proteins, GPCRs, effectors, and regulatory proteins, there is a great 
deal of versatility among the signal transduction mechanisms throughout the different cell 
types of the body (for review see McCudden et al., 2005; Wettschureck and Offermanns, 
2005).    
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Neuronal calcium channels are directly regulated by both Gα and Gβγ subunits as 
well as indirectly regulated by G-proteins through second messenger systems (for review 
see Schultz et al., 1990; Dolphin, 1998; Wettschureck and Offermanns, 2005).  N-type 
and P/Q-type calcium channels are directly inhibited by Gβγ in a membrane delimited 
manner (for review see Tedford and Zamponi, 2006).  Gβγ subunits remain anchored to 
the plasma membrane, whereas the Gα subunit can diffuse throughout the cytoplasm.  
(Herlitze et al., 1996; Ikeda et al., 1996).  Binding of the Gβγ subunits to the intracellular 
loop between domains I and II of the α1 subunit of VDCCs makes it more difficult for the 
channel to open (Bean, 1989b; Boland and Bean, 1993; Herlitze et al., 1997; Zamponi et 
al., 1997; for review see Tedford and Zamponi, 2006).  In addition to direct binding, G-
proteins can activate second messenger systems that activate protein kinases, which can 
in turn regulate calcium channel activity.  Phosphorylation of the channel protein itself or 
a regulatory component can either stimulate or inhibit channel activity.   
The signal transduction mechanism of L-type calcium current facilitation by 
GABAB receptor activation in the mammalian nervous system has not been identified and 
was a main focus of my research project.  GABAB receptor activation of PKC has been 
shown to facilitate L-type current in salamander retinal neurons (Shen and Slaughter, 
1999).  PKC activation within the hippocampus has also been shown to enhance L-type 
calcium current (Doerner et al., 1990; Doerner and Alger, 1992).  However, this 
facilitation was not linked to GABAB receptor activation.  Shen and Slaughter (1999) also 
demonstrated inhibition of the facilitation of L-type calcium current by GABAB receptor 
activation in the salamander retina in the presence of a PKA inhibitor, but the response 
was smaller than the blockade of facilitation seen with PKC inhibitors.  The present 
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project directly investigated the role of PKC and PKA in GABAB receptor mediated 
facilitation of L-type calcium current within the neonatal rat hippocampus using multiple 
PKC and PKA inhibitors as well as activators for both PKC and PKA.    
 
Protein Kinase C 
 PKC represents a family of serine/threonine protein kinases that are stimulated by 
diacylglycerol (DAG), calcium, and phospholipids.  The structure of PKC includes a 
highly conserved catalytic domain along with a regulatory domain that keeps the kinase 
in an inactive conformation (Figure 1.7; for review see Steinberg, 2008).  Activation of a 
Gαq family protein and certain Gβγ subunits results in the activation of PLC, which in 
turn cleaves the membrane lipid phosphatidylinositol bisphosphate (PIP2) into DAG and 
inositol trisphosphate (IP3).  DAG stays within the membrane and activates PKC (Figure 
1.8).  Activated PKC can then phosphorylate target proteins, such as sodium, potassium, 
and calcium channels.   
DAG
Calcium
Inactive
Active
PS
 
 
Figure 1.7: PKC is a monomeric protein.  Certain isoforms require Ca2+, 
DAG, and phosphatidylserine (PS) for activation and relief of autoinhibition.   
   
There are at least 12 different isoforms of PKC, which are classified into three 
classes based on their activation requirements (Tanaka and Nishizuka, 1994; Nishizuka, 
1995; Webb et al., 2000; Zarate and Manji, 2009).  The conventional PKC isoforms are  
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Figure 1.8: PKC pathway. PLC can be activated by the Gq family of Gα 
subunits as well as certain Gβγ subunits. The activated phospholipase cleaves 
PIP2 into IP3 (inositol trisphoshpate) and DAG.  IP3 initiates intracellular calcium 
release from the endoplasmic reticulum, which induces the translocation of PKC 
to the plasma membrane.  PKC is activated by the combination of DAG, calcium, 
and phospholipids. Once activated, PKC is able to phosphorylate target proteins. 
 
α, βI, βII, and γ.  These isoforms require calcium and DAG for activation.  There are five 
novel PKC isoforms, δ, ε, η, θ, and µ.  The novel PKC isoforms do not require calcium 
for activation, but do require DAG for activation.  Lastly, the atypical PKC isoforms, ζ, λ, 
and ι, require neither calcium nor DAG for activation (Tanaka and Nishizuka, 1994; 
Webb et al., 2000; Zarate and Manji, 2009).  In addition to differences in their mode of 
activation, the different isoforms of PKC also vary in their structure, subcellular 
localization, and tissue specificity.  Multiple PKC isoforms can exist within a single cell, 
but the subcellular localization may differ for each isoform.  Thus, each isoform may be 
involved in regulating different cell functions throughout various regions of the cell 
(Roisin and Barbin, 1997).   
 
 
 
Table 3: PKC isoforms are divided 
into three subfamilies based on their 
mode of activation. 
 
 
Subfamilies of 
PKC Isoforms 
Activation 
Requirements 
Conventional α, βI, βII, γ 
Ca2+, DAG, 
Phospholipid 
Novel δ, ε, η, θ, µ DAG and Phospholipid 
Atypical ζ, ι, λ Phospholipid 
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All known PKC isoforms have been shown to be expressed in the mammalian 
CNS (Tanaka and Nishizuka, 1994).  However, all of the PKC isoforms have a very 
specific tissue distribution at different developmental time points in the CNS (Oehrlein et 
al., 1998).  PKC is present in high concentrations in hippocampal neurons and plays a 
large role in many developmental processes, such as neuronal differentiation (Webb et 
al., 2000).  Various PKC isoforms are present in hippocampal neurons at different 
developmental stages.  A study by Roisin and Barbin (1997) looked at the presence of 
several different PKC isoforms (α, β, ε, γ, and ζ) in hippocampal cultures isolated from 
embryonic rats as well as in hippocampal protein extracts isolated from postnatal rat pups 
of varying ages using Western blot analysis (Figure 1.9).  When analyzing protein 
content at specific ages, PKC α (∆) is expressed at low levels until postnatal day 4 where 
it begins to rise (Figure 1.9A).  In comparison, PKC γ (▲) is barely detectable until 
postnatal day 14.  PKC ε (●) is detectable in the hippocampal preparations isolated from 
embryonic rats with protein levels peaking during the first postnatal week.  PKC β (○) 
levels are low in embryonic tissue, but begin to rise starting postnatal day 0. There were 
two immunoreactive bands for PKC ζ (75 kDa and 83 kDa), which demonstrate different 
expression patterns throughout development (Figure 1.9B).  The 75 kDa band (■) is more 
highly expressed in the embryonic hippocampus and is not highly expressed past the 
second postnatal week, whereas the 83 kDa band (□) protein levels peak after the first 
postnatal week (Roisin and Barbin, 1997).  This is one of the few studies to explore the 
presence of the different PKC isoforms within hippocampal neurons during development.  
Since this study is well over ten years old, not all of the PKC isoforms were investigated.  
 24
 
 
Age (days)
E17 E18 E19 P0 P4 P7 P14 P21 P60
PK
C 
Im
m
u
n
o
re
ac
tiv
ity
 
(%
)
0
20
40
60
80
100
A
Age (days)
E17 E18 E19 P0 P4 P7 P14 P21 P60
PK
C 
Im
m
u
n
o
re
ac
tiv
ity
 
(%
)
0
20
40
60
80
100
ζ
ζ 83 kDa
75 kDa
B
α
β
ε
γ
 
 
Figure 1.9:  PKC isoforms vary throughout hippocampal development.  Quantitative analysis by 
Western blot of PKC isoform expression in hippocampal protein extracts from rats of varying 
ages. (A) For PKC α, β, γ, and ε isoforms, data are expressed as the percentage of the value 
measured in the adult hippocampus.  (B) For PKC ζ two bands were immunodetected.  Each 
value is the mean of three determinations. Adapted from Neurochemistry International. Vol. 30, 
No. 3, Roisin MP, Barbin G, Differential expression of PKC isoforms in hippocampal neuronal 
cultures: Modifications after basic FGF treatment, 261-270, 1997, with permission from Elsevier. 
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Very few investigators have studied L-type calcium channel modulation by PKC 
and the studies that have been published demonstrate several conflicting results.  There 
are many factors involved in determining whether phosphorylation of L-type calcium 
channels by PKC can either result in an increase or a decrease of calcium current.  These 
include the type of cell, the type of calcium channel present, the type of accessory 
proteins associated with the calcium channels, as well as the specific isoform of PKC that 
is activated.  PKC activation enhances L-type calcium current in cardiac myocytes, but 
CaMKII has also been shown to be involved in the signaling pathway (O-Uchi et al., 
2008).  When Cav1.3 channels were heterologously expressed in HEK cells, PKC 
activation with phorbol esters decreased whole-cell Cav1.3 current (Baroudi et al., 2006).  
Using single-channel recording, it was demonstrated that PKC activation reduced Cav1.3 
current open probability, by decreasing open time and increased closed time (Chahine et 
al., 2007).  Studies comparing the peak and sustained component of whole-cell currents 
in dorsal root ganglion cells from fetal mice in response to PKC activation, demonstrated 
a decrease in N-type calcium current with no effect on L-type calcium current (Gross and 
MacDonald, 1989).  Each of these studies demonstrate a different response to PKC 
activation, either an increase, no change, or a decrease in L-type calcium current.  These 
demonstrate the complexity of the signaling pathways involved in the regulation of 
calcium channels and the various factors that can affect the response to PKC activation.   
PKC has also been shown to modulate the other HVA calcium channel types, N-
type, P/Q-type and R-type calcium channels. When heterologously expressed in HEK 
cells, phosphorylation of both N-type and P/Q-type calcium channels by PKC increased 
the activity of the channels and also decreased the amount of inhibition of the channels 
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by Gβγ (Swartz, 1993; Zamponi et al., 1997; Herlitze et al., 2001).  In Xenopus laevis 
oocytes, PKC activation enhanced both heterologously expressed N-type and R-type 
calcium currents, but did not affect either P/Q-type or L-type Cav1.2 calcium current 
(Stea et al., 1995).  Stea et al., (1999) also determined that the enhancement of N-type 
and R-type calcium current was dependent on the coexpression of a β subunit.  In 
comparison, other studies have shown that PKC activation can decrease N-type calcium 
current in the dorsal root ganglia of chick embryos through activation of α2-adrenergic 
receptors by norepinephrine (Diversé-Pierlussi et al., 1993, 1995).  In these cells N-type 
calcium current inhibition by activation of GABAB receptors with GABA is not 
dependent on PKC (Diversé-Pierlussi et al., 1993, 1995).  PKC inhibitors had no effect 
on the GABA induced inhibition of N-type current in dorsal root ganglion cells.  Using 
guinea pig hippocampus, Doerner et al. (1990) demonstrated N-type calcium current 
inhibition in response to direct activation of PKC in pyramidal cells, but they did not look 
for any effects in interneurons.  Although expression of calcium channels in heterologous 
systems has provided a wealth of information about the characteristics of calcium 
channels and signaling mechanisms involved in their regulation, these mechanisms may 
be different to what is seen in native tissues.   
 
Protein Kinase A 
 Many cellular functions involve the second messenger cyclic adenosine 3’,5’-
monophosphate (cAMP), whose concentration is modulated by adenylyl cyclase and 
phosphodiesterase (PDE) activity.  Increased cAMP levels within neurons activates 
cAMP-dependent kinase or PKA, which phosphorylates target proteins.  When in its 
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inactive form, PKA is a tetrameric structure consisting of two regulatory subunits along 
with two catalytic domains (Figure 1.10).  There are four different regulatory subunits 
(RIα, RIβ, RIIα, RIIβ) and three catalytic subunits (Cα, Cβ, Cγ; for review see 
McKnight et al., 1988; Doskeland et al., 1993; Brandon et al., 1997).  Each regulatory 
subunit contains two cAMP binding sites (Taylor et al., 1990).  Following binding of 
cAMP to the regulatory subunit, a conformational change occurs that results in the 
dissociation of the catalytic subunits.  Once released from the regulatory subunits, these 
monomeric catalytic subunits are now active and able to phosphorylate serine and 
threonine residues on downstream target proteins.   
 
C C C C
+ R R
+ 
Inactive PKA Active PKA
cAMP R R
 
 
Figure 1.10: The structure of PKA consists of two regulatory subunits (R) and two 
catalytic subunits (C).  In the absence of cAMP, the catalytic subunits associate with 
the regulatory subunits.  As a result of cAMP binding, a conformational change in the 
regulatory subunit releases the catalytic subunits. The active catalytic subunits are 
free to phosphorylate proteins. 
 
Adenylyl cyclase is an enzyme that synthesizes cAMP from adenosine-5'-
triphosphate (ATP).  Adenylyl cyclase activity can be either stimulated by Gαs resulting 
in an increase in cAMP levels or inhibited by Gαi resulting in decreased cAMP levels.  
cAMP levels are also controlled by PDE, an enzyme that breaks down cAMP.  PKA 
regulates several functions within different cell types, including cellular metabolism, 
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changes in gene expression, cell and tissue development, neuronal excitability, ion 
channel conductivity, and changes in synaptic plasticity (for review see Brandon et al., 
1997; Nguyen and Woo, 2003).  Phosphorylation of L-type calcium channels by 
PKA often leads to the enhancement of intracellular Ca2+ concentration.  For example in 
skeletal muscle, Cav1.1 L-type calcium current is enhanced through PKA 
phosphorylation of a single serine residue (Ser 1982) in the C-terminus of the α1 subunit 
(De Jongh et al., 1996).  This enhancement in intracellular Ca2+ levels ultimately 
increases the force of the contraction (Schmid et al., 1985; Arreola et al., 1987; 
Sculptoreanu et al., 1993a).  Within the heart, β-adrenergic receptor activation leads to 
the enhancement of L-type calcium current through phosphorylation by PKA (for review 
see Kamp and Hell, 2000).  Direct PKA activation by 8-Br-cAMP increases both the 
mean channel open time and probability of Cav1.2 L-type calcium channels in cultured 
rat cardiac myocytes (Reuter et al., 1982; Cachelin et al., 1983).  Therefore, it is possible 
that PKA is involved in the signaling pathway of L-type calcium current by GABAB 
receptors in the neonatal rat hippocampus.   
 
 The overall goal of this research project was to continue exploring the novel 
phenomenon of L-type calcium current facilitation by GABAB receptor activation within 
the neonatal rat hippocampus.  The first set of experiments investigated the 
developmental time course of L-type current facilitation by GABAB receptor activation in 
the first two developmental weeks to determine at which age facilitation was most 
prominent.  Since many other investigators use either embryonic or adult hippocampal 
tissue for their studies rather than neonatal tissue, the facilitation of L-type calcium 
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current by GABAB receptor activation had not been previously demonstrated.  The 
GABAergic system is not yet fully developed in embryonic hippocampal tissue and 
hippocampal cultures isolated from embryonic rats contain mostly excitatory pyramidal 
cells (Banker and Cowan, 1979; Scholz and Miller, 1991).  Only 5-10% of neurons 
demonstrate GABA immunoreactivity in hippocampal cultures isolated from E17 rats, 
which is consistent with the excitatory synaptic potentials predominately observed in E17 
embryonic cultures (Scholz and Miller, 1991).  A greater percentage (12-36%) of neurons 
express GABA in cultures isolated from E18 rats (Scholz and Miller, 1991).  Since there 
are very few GABAergic neurons in cultures isolated from early embryonic hippocampi, 
it could explain why facilitation of L-type calcium current has not been observed.  
Although the GABAergic system is fully developed in brain slices, it is problematic 
looking at receptor mediated effects on current in slices because the cells have many 
processes making it difficult to control the voltage.  In acutely dissociated adult 
hippocampal damage occurs to surface proteins by either physical damage or trypsin 
mediated digestion and thus acute isolations are not an ideal preparation for these types of 
experiments.  Hippocampal neurons isolated from adult tissue will not survive overnight 
in culture, whereas hippocampal neurons isolated from neonatal tissue will survive 
overnight in culture.  Waiting overnight allows enough time for the neurons to recover 
from dissociation and for the reinsertion of channels or receptors.  In addition, functional 
effects are likely to differ greatly in neonate versus adult due to major changes in the 
GABAergic system during the early neonatal period.  Since facilitation has only been 
observed in neonatal cultures, it is possible that L-type calcium current facilitation could 
be involved in a developmentally regulated process.   
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 Secondly, the role that L-type calcium current facilitation played in the regulation 
of chloride transporters during the maturation process of the GABAergic system was 
investigated.  Due to the different subcellular distribution of N-type and L-type calcium 
channels on neurons in vivo, L-type channels are not generally linked to the regulation of 
neurotransmitter release.  Rather activation of L-type calcium channels, which are 
localized on the cell body and dendritic region of neurons, can lead to a number of 
cellular effects ranging from gene activation to changes in postsynaptic activity 
(Westenbroek et al., 1990; Bading et al., 1993; Budde et al., 1998).  It is possible that 
GABAB receptor mediated facilitation of L-type calcium current during the first few 
weeks of development may play a role in the regulation of chloride transporters that are 
necessary for the maturation of the GABAergic response in neurons.   
 Lastly, the signal transduction pathway of GABAB receptor modulation of L-type 
calcium channels in hippocampal neurons was explored using several kinase inhibitors as 
well as kinase activators.  Since L-type calcium channels have several consensus sites for 
phosphorylation by kinases, the involvement of both PKC and PKA in the signaling 
pathway was investigated.  Both PKC and PKA have been implicated in the signal 
transduction pathway of GABAB receptor facilitation of L-type calcium current in 
salamander retinal cells (Shen and Slaughter, 1999).  Therefore, it is likely that PKC and 
PKA may be involved in the facilitation of L-type calcium current by GABAB receptor 
activation within the neonatal rat hippocampus.   
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CHAPTER 2 
MATERIALS AND METHODS 
Isolation of Hippocampal Neurons 
 All animal protocols were approved by the Marquette University Institutional 
Animal Care and Use Committee and followed the guidelines set forth by the U.S. Public 
Health Service.  Neurons were isolated by a technique developed for the hippocampus of 
postnatal rats as published previously (Mynlieff, 1997).  Sprague-Dawley rat pups of 
varying ages were anesthetized with CO2 and sacrificed by decapitation.  The head was 
immersed in 70% ethanol for 3 minutes for decontamination and rinsed in sterile rodent 
Ringer’s solution with glucose (146 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 
10 mM HEPES, 11 mM D-glucose, pH 7.4 with NaOH).  The hippocampi were dissected 
from the brain in oxygenated, cold (~5°C), sterile rodent Ringer’s solution with glucose 
using sterile technique.  For electrophysiology experiments, dissections were restricted to 
the superior region of the hippocampus (excluding the dentate gyrus).  For protein 
analysis of transporters, the entire hippocampus was used for cultures.  The tissue was 
placed in PIPES-buffered saline (120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 
25 mM D-glucose, 20 mM piperazine-N,N’-bis[2-ethanesulfonic acid], pH 7.0 with 
NaOH) and sliced into ~1 mm3 sections.  The tissue was transferred into a small vial and 
incubated at room temperature in 1 ml of 0.5% Trypsin XI and 0.01% DNase I (Sigma-
Aldrich, St. Louis, MO) in PIPES buffered saline at room temperature for 20-30 minutes 
with 100% oxygen blown over the tissue.  This incubation was followed by another 
incubation for 40-60 minutes depending on the age of the pup at 35°C under continuous 
oxygen.  The tissue was rinsed with 1 ml trypsin inhibitor solution (1 mg/ml trypsin 
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inhibitor, Type II-O: chicken egg white (Sigma-Aldrich, St. Louis, MO) and 1 mg/ml 
bovine serum albumin) in rodent Ringer’s solution and rinsed again with 1 ml 
Neurobasal-A growth medium fortified with B27 supplement (Invitrogen, Carlsbad, CA), 
0.5 mM glutamine, and 0.02 mg/ml gentamicin.  The tissue was triturated with a fire-
polished Pasteur pipette in fresh growth medium and plated onto the center of poly-L-
lysine coated dishes for both electrophysiology and protein analysis.  The culture dishes 
were coated with 1mg/ml of poly-L-lysine (MW 38,500 to 60,000, Sigma-Aldrich, St. 
Louis, MO) dissolved in 0.15 M boric acid (pH of 8.4 with NaOH).  A detailed protocol 
for making poly-L-lysine dishes can be found in Mynlieff (1997).  Cells were allowed to 
settle to the bottom of the dish for 5 minutes prior to the addition of growth medium to 
bring the volume up to 2 ml per dish.  Neurons were incubated at 37°C in a 5% CO2 
water-jacketed incubator.   
 There are many advantages to using cultured cells for electrophysiological 
studies.  Cultured cells have very few processes which allows for proper control over 
voltage and prevents space clamp issues when performing patch clamp recordings.  In 
addition, it is possible to apply compounds directly to an individual cell without 
contaminating other cells within the culture by using a U-tube system (Mynlieff, 1997).  
Cultured cells provide much more stable recordings compared to acutely isolated 
hippocampal cells.  Waiting 20 - 24 hours after dissociation allows time for the 
reinsertion of channels and receptors after the processes have been sheared off.  For 
example, N-type and P/Q-type calcium channels, which are primarily found on processes, 
are reinserted into the cell body of the neuron (Figure 2.1; courtesy of Katie Halstead, a 
former undergraduate).  Therefore, it is possible to study the modulation of channels 
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normally found in the synapse on the soma.  Hippocampal cultured neurons isolated in 
the Mynlieff laboratory retain their electrophysiological properties and firing properties 
after dissociation (Mynlieff, 1997, 1999).   
 
 
 
Figure 2.1:  Reinsertion of HVA calcium channels.  To determine the presence 
of different HVA calcium channel types, hippocampal cultures isolated from 
postnatal rats 6 to 9 days old were labeled with primary antibodies against the α1 
calcium channel subunits 24 hours following dissociation.  All cultures treated 
with antibodies 24 hours after dissociation displayed staining for all of the α1 
subunits tested, suggesting that 24 hours is sufficient time for the reinsertion and 
stabilization of calcium channels in the membrane.  Approximately only 20% of 
the cells stained darkly for the CaV1.2 (L-type) calcium channel, while almost 
100% of the cells stained uniformly and intensely with the CaV1.3 (L-type) 
calcium channel.  Data was obtained by Katie Halstead.   
 
 
Control CaV2.1 (P-type) CaV2.2 (N-type) 
CaV1.2 (L-type) CaV1.3 (L-type) CaV2.3 (R-type) 
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Hippocampal cultures isolated from embryonic rat pups are predominantly 
comprised of excitatory pyramidal cells, and thus are not ideal for the study of 
hippocampal interneurons (Banker and Cowan, 1979; Scholz and Miller, 1991).  One of 
the benefits of using postnatal rat hippocampal cultures is that they are highly enriched in 
interneurons, making them an ideal system for studying the effects of GABAB receptor 
modulation of calcium channels during development.  When cultures isolated from a 7 
day old postnatal rat were labeled with anti-GABA antibodies, 41.8 ± 5.0% of the 
neurons contained GABA suggesting that almost 50% of the cells in the culture were 
GABAergic inhibitory interneurons (Mynlieff, 1997).  One of the disadvantages to using 
cultured neurons is that the superior region of the hippocampus (CA1 and CA3) contains 
pyramidal cells along with several different types of inhibitory interneurons.  After such a 
short time in culture it is not possible to identify the cells based on morphology 
(Mynlieff, 1997).     
 
Electrophysiology 
Whole cell patch clamp recording was used to measure calcium currents in 
voltage clamp mode.  Data were collected using a Dagan 3900A patch clamp amplifier 
(Dagan Corporation, Minneapolis, MN) combined with a Digidata 1322 data acquisition 
system and a computer with pCLAMP 9.0 software (Molecular Devices, Sunnyvale, CA).  
All electrophysiological experiments were performed at room temperature 20-24 hours 
following dissociation.  Although voltage control is best immediately following 
dissociation, it was necessary to wait overnight to allow the cells time to recover from 
enzymatic dissociation and adhere to the bottom of the dish (Mynlieff, 1997).  Recording 
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electrodes (3-7 MΩ) were made from borosilicate glass capillaries on a Flaming/Brown 
Micropipette Puller model P-87 (Sutter Instrument Co., Novato, CA).  The internal 
solution used to fill the patch electrodes contained 140 mM Cs-aspartate, 5 mM MgCl2, 
10 mM Cs2EGTA, 10 mM HEPES, 2 mM ATP-Na2, and 0.1 mM GTP (pH of 7.4 with 
CsOH and osmolarity between 310-320 mOsm).  The external solution used for calcium 
current measurements contained 10 mM CaCl2, 145 mM TEACl, 10 mM HEPES and 1 
µM tetrodotoxin (Sigma-Aldrich, St. Louis, MO) to block Na+ currents (pH of 7.4 with 
CsOH and osmolarity between 300-310 mOsm).  Whole cell currents were electronically 
filtered at 1 kHz and digitized at 2 kHz.  Linear components of leak current were 
subtracted post-hoc by the passive resistance protocol in pClamp 9.0.  
 For the majority of the electrophysiology experiments, the sustained component 
of the calcium current was used versus the peak component of the calcium current 
(Figure 2.2). The peak current is a combination of several different types of calcium 
current, which can hamper the interpretation of these data.  Since L-type calcium 
channels exhibit slow inactivation kinetics, the sustained current component at the end of 
the 300 msec depolarization pulse to +10 mV was measured to minimize the contribution 
of T-type, N-type, P/Q-type, and R-type calcium current while maximizing the 
contribution of L-type calcium current to the total measurement.  The inactivation rate for 
L-type calcium current is very slow (τ > 500 msec), whereas the inactivation rates for N-
type, P/Q-type, and R-type calcium current is fast (τ ≈ 50-80 msec; Tsien et al., 1988).  
There may still be contributions of the other current types at the end of the 300 msec 
pulse, but the majority of the sustained current should be primarily comprised of L-type 
current due to its slower inactivation kinetics when compared to the other HVA calcium 
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current types.  Previous studies in which nimodipine, an L-type calcium channel 
antagonist, blocked the ability of baclofen to facilitate sustained current have confirmed 
that the facilitatory effect of GABAB receptor activation on calcium currents was entirely 
mediated through L-type channels (Carter and Mynlieff, 2004). 
 
 
 
Figure 2.2:  Peak versus sustained current.  
Calcium currents were elicited by a 300 
msec depolarization to +10 mV from a 
holding potential of -80 mV.  The peak 
current is measured at the beginning of the 
300 msec pulse, while the sustained current 
is measured at the end of the 300 msec 
pulse. 
  
 
 
Drugs and Enzymes Used in Electrophysiology Experiments 
 Multiple kinase inhibitors with different chemical structures as well as specific 
kinase activators were used for verification of results on whether PKC and/or PKA are 
involved in the signal transduction pathway of L-type calcium current facilitation by 
GABAB receptor activation.  At certain concentrations kinase inhibitors can lose their 
specificity for a particular kinase, therefore the concentrations used for each compound 
were carefully chosen.  Experimental concentrations were determined by examining the 
literature as well as comparisons with the IC50 / EC50 (Table 4).  If a compound interacted 
with a single kinase a higher concentration could be used, whereas lower concentrations 
were necessary for compounds that were less specific for a particular kinase and may 
interact with other kinases at higher concentrations.  
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Compound Action Concentration Used IC50 / EC50 
PKC fragment 19-36 inhibits PKC 2 µM 147 nM 
GF-109203 X inhibits PKC 500 nM 10 nM  
Chelerythrine Chlroide inhibits PKC 5 µM 0.66 µM 
Phorbol Ester (PMA) activates PKC 1 µM 1 nM 
H-89 dihydrochloride hydrate inhibits PKA 1 µM 48 nM 
Rp-cAMPS inhibits PKA 30 µM 11 µM 
8-BR- cAMP activates PKA 500 µM 166 µM 
Table 4: Kinase activators and inhibitors for PKC and PKA. The above compounds were used to 
investigate the signal transduction mechanism of L-type calcium current facilitation by GABAB 
receptor activation.    
 
(RS)-baclofen (Tocris, Ellisville, MO) and 8-Bromoadenosine 3´, 5´- cyclic 
monophosphate (8-Br-cAMP, Sigma-Aldrich, St. Louis, MO) were directly dissolved in 
the external calcium solution.  GF-109203X (AG Scientific, INC., San Diego, CA) and 
phorbol-12-myristate-13-acetate (PMA, Calbiochem, La Jolla, CA) were dissolved in 
dimethyl sulfoxide (DMSO) at 1000 - 5000 fold the final concentration.  Rp-cAMPS 
triethylammonium salt hydrate, H-89 dihydrochloride hydrate, and chelerythrine chloride 
(Sigma-Aldrich, St. Louis, MO) were dissolved in water at 333 – 10,000 fold the final 
concentration.  All concentrated stock solutions of the drugs were stored at -20°C until 
use up to two months.  These compounds were diluted to their final concentration in the 
external calcium solution on the day of use.  The drugs dissolved in the external calcium 
solution were applied to cells using a U-tube delivery system, constructed with PE-10 
polyethylene tubing housed in a piece of glass tubing, which allowed for quick 
application and washout of compounds that were gravity fed onto the cell and removed 
by vacuum suction.  A blue dye, Fast Green FCF (Sigma-Aldrich, St. Louis, MO), was 
added to the drug solution to visualize application of the drug onto the cell and to ensure 
complete washout of the drug off the cell.  Protein kinase C fragment 19-36 (Sigma-
Aldrich, St. Louis, MO) was dissolved in 1% acetic acid and included in the internal 
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solution with less than a 0.1 change on the pH of the internal solution.  Pertussis toxin 
(PTX, Sigma-Aldrich, St. Louis, MO) was dissolved in distilled water at 500 fold the 
final concentration with bovine serum albumin (4 mg/ml) added for stabilization.  
Cultures were exposed to 200 ng/ml PTX for a minimum of 16 hours starting two hours 
after dissociation.  A longer exposure time is necessary with PTX treatment, to ensure 
complete inhibition of Gi/o proteins.  This concentration and time of pre-treatment is 
similar to the concentration (250 ng/ml) and time of PTX  exposure (26 hrs) that Scholz 
and Miller (1991) used to demonstrate the effect of baclofen on calcium currents in 
hippocampal cell cultures.  Higher concentrations as well as a longer PTX exposure time 
would be necessary for complete inhibition of Gi/o proteins if hippocampal slices were 
being used for electrophysiological experiments.   
 
Electrophysiology Data Analysis and Statistics 
To analyze electrophysiological data, the magnitudes of the currents in response 
to a +10 mV depolarizing pulse were plotted as a scatter graph vs. time.  The linear 
regression and 95% confidence intervals were determined for the control current data 
points and were used to determine the effect of 10 µM baclofen application on calcium 
current amplitude as described in Carter and Mynlieff (2004).  Multiple control currents 
were measured before and after drug application.  This allowed for compensation due to 
run-up or run-down of calcium currents (Figure 2.3).  The percent change with baclofen 
application was determined by comparison to the regression line.  The cells were grouped 
according to whether baclofen application caused a deviation in the magnitude of the 
calcium current when compared to the linear regression line determined by the control 
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data.  The change in current magnitude was considered significant if it fell outside of the 
95% confidence interval for the regression line.  If the current with baclofen application 
fell above the 95% confidence interval the cells were grouped as demonstrating an 
increase in current and if it fell below the cells were grouped as demonstrating a decrease 
in current.  In cells where the current with baclofen application fell within the 95% 
confidence interval, the cells were grouped together as demonstrating no change.   
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Figure 2.3: Analysis of calcium currents. Calcium currents were elicited by a 300 msec 
depolarization to +10 mV from a holding potential of -80 mV. These data represent sustained 
calcium currents recorded from cultured hippocampal neurons isolated from 7 day old rats.  The 
linear regression (solid line) and 95% confidence interval (dashed line) were determined for the 
control currents (●). The percent change with 10 µM baclofen application (▲) was determined by 
comparison to the regression line.  In all cells where the current with baclofen fell within the 95% 
confidence interval the effect was counted as “no change”.   
 
In experiments where kinase inhibitors or kinase activators were used, a 
contingency table was set up as a 2X3 table where row 1 and row 2 contained control 
cells and cells treated with a particular compound.  The three columns contained the 
number of cells in each row demonstrating an increase, no change, or a decrease in 
sustained calcium current in the presence of baclofen.  A chi-square was used to 
determine whether the columns in the contingency table vary from row to row.  A Fisher 
exact test was used for pairwise comparisons.  To determine whether the number of cells 
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that demonstrated an increase in calcium current with baclofen application in the absence 
and presence of a drug was significantly different, the number of cells that demonstrated 
no change or a decrease in calcium current with baclofen application were grouped 
together making the pair-wise comparison between the cells demonstrating an increase 
and “other” (cells demonstrating a decrease plus cells demonstrating no change).  The 
opposite was done to determine whether the number of cells that demonstrated a decrease 
in calcium current with baclofen application in the absence and presence of a drug was 
significantly different.  For this case the number of cells that demonstrated no change or 
an increase in calcium current with baclofen application were grouped together making 
the pair-wise comparison between the cells demonstrating a decrease and “other” (cells 
demonstrating an increase plus cells demonstrating no change).  Averaged data are 
always given as mean ± standard error of the mean (S.E.M.). 
 
Western Blot Analysis 
For Western blot analysis, whole hippocampal tissue was obtained from rats 
ranging from 1 to 42 days old (D1 to D42) and from hippocampal cultures that were 
obtained from postnatal day 0 rats and kept in culture for 1 to 15 days (C0-1 to C0-15).  
A total volume of 2 ml of medium was maintained for cultures that were used for protein 
analysis of transporters.  Twenty four hours after plating the cells, 1 ml of growth 
medium was removed and fresh medium was added to the dish.  A volume control dish 
containing 2 ml of growth medium was placed in the incubator and the appropriate 
amount of fresh medium was added every other day to maintain the correct volume.  For 
cultures treated with drugs, 2 µl of stock solutions of either 5 mM nimodipine (Sigma-
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Aldrich, St. Louis, MO) dissolved in 5 M HCl or 10 mM (RS)-baclofen (Tocris, 
Ellisville, MO) dissolved in methanol, were added daily for a total of seven days to 
maintain concentrations of 5 µM or 10 µM, respectively.  In addition, a few cultures were 
also treated with 2-hydroxysaclofen (Tocris, Ellisville, MO), a GABAB antagonist.  The 
2-OH-saclofen was dissolved in 1 M NaOH to give a 10 mM stock solution.  To maintain 
a 10 µM concentration, 2 µl of the 2-OH-saclofen stock solution was added daily for a 
total of seven days.  Chloride transporter levels were also tested in cultures treated with 
drug vehicles alone (methanol, HCl, and NaOH).  No significant differences were found 
in transporter expression levels in comparison to the control cultures (Courtesy of Eddie 
Brotkowski).   
Proteins were extracted by homogenization in an ice-cold sucrose buffer (250 mM 
sucrose, 10 mM Tris, 10 mM HEPES, 1 mM EDTA, pH 7.2) with fresh protease 
inhibitors (1 µg/ml pepstatin, 1 µg/ml leupeptin, 0.5 mg/ml pefabloc; Sigma-Aldrich, St. 
Louis, MO) followed by centrifugation at 3622 x g for 10 minutes at 4°C.  The 
supernatant was centrifuged at 39,104 x g for 30 minutes at 4°C.  The final pellet was 
resuspended in homogenizing buffer and stored at -80°C for less than 6 months.  Protein 
concentration was measured with an enhanced BCA protein assay (Pierce, Rockford, IL).   
NuPAGE lithium dodecyl sulfate (LDS) sample buffer and sample reducing agent 
(Invitrogen, Carlsbad, CA) were added to the membrane extracts and heated at 37°C for 
30 minutes. The membrane extracts were run on a 3-8% Tris-acetate Novex Minigel and 
transferred to a polyvinylidene difluoride (PVDF) membrane (pore size 0.45 µm) for 
KCC2 experiments and a nitrocellulose membrane (pore size 0.45 µm) for NKCC1 
experiments in NuPAGE transfer buffer (Invitrogen, Carlsbad, CA).  The membranes 
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were washed with phosphate buffered saline (PBS, 134.4 mM NaCl, 4.36 mM KCl, 10.56 
mM Na2HPO4, 1.66 mM NaH2PO4 and pH to 7.4 with HCl) and blocked for 1 hour in 
PBS containing 0.05% Tween, 5% nonfat dry milk, and 0.1% bovine serum albumin at 
room temperature.  The membranes were decorated with primary antibodies in the PBS 
blocking solution against KCC2 (1:1000; Upstate Technologies, New York, NY) or 
NKCC1 (1:2000; Developmental Studies Hybridoma Bank, University of Iowa, Iowa 
City, IA) overnight at 4°C.  Following a 1 hour wash in PBS, the membranes were 
incubated with either a goat anti-rabbit or goat anti-mouse HRP-conjugated secondary 
antibody (1:1000; Pierce, Rockford, IL) in the PBS blocking solution for 2 hours at room 
temperature.  The SuperSignal West Dura Extended Duration chemiluminescent 
enhancement kit (Pierce, Rockford, IL) was used to visualize the protein bands with 
classic blue autoradiography film (Molecular Technologies, St. Louis, MO).   
 
Quantification of Western Blots 
To quantify protein on Western blots, the background intensity was first 
subtracted using ImageJ software (developed at U.S. National Institutes of Health and 
available at http://rsb.info.nih.gov/ij/).  The integrated optical density (IOD) for each 
band was determined using Labworks 4.6 imaging and analysis software (UVP, Inc., 
Upland, CA).  To control for gel loading, the IOD for each protein was divided by the 
IOD of a band in the same lane labeled with either anti-β-actin antibodies (1:1000; Cell 
Signaling Technologies, Danvers, MA) or anti-β-tubulin antibodies (1:5000; Sigma-
Aldrich, St. Louis, MO).  Multiple protein samples were analyzed per developmental 
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time point studied for both whole hippocampal protein extracts and cultured hippocampal 
protein extracts.  Averaged data are always given as mean ± S.E.M. 
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CHAPTER 3 
 
 
 
 
 
 
 
 
 
 
 
The developmental time course of L-type calcium current 
facilitation by GABAB receptor activation within  
the rat hippocampus 
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 INTRODUCTION 
 The maturation and role of GABAA receptors early in neonatal development has 
been extensively studied.  In comparison, there is considerably less known about the 
developmental changes of GABAB receptors. The current study was designed to enhance 
our knowledge of GABAB receptor function during development.  Previous 
electrophysiological experiments in the lab performed on hippocampal neurons 
dissociated from the superior region of 5 to 7 day old rat pups have demonstrated both an 
inhibition and facilitation of calcium current in response to GABAB receptor activation 
(Carter and Mynlieff, 2004).  Using specific calcium channel blockers Carter and 
Mynlieff (2004) confirmed that attenuation of calcium current was through N-type 
calcium channels while facilitation was through L-type calcium channels.  GABAB 
receptor facilitation of HVA calcium current has been shown in a number of cell types, 
including salamander retinal neurons (Shen and Slaughter, 1999), adrenal chomaffin cell 
cultures (Parramόn et al., 1995), and rat dorsal root ganglion (Fujikawa et al., 1997).  In 
both salamander retinal neurons and adrenal chromaffin cell cultures, the facilitation of 
calcium current was blocked by DHPs, demonstrating that the effect was entirely through 
L-type calcium channels.  The type of HVA calcium current involved in the facilitation 
by baclofen in dorsal root ganglion was not investigated (Fujikawa et al., 1997).   
Calcium is one of the most important intracellular messengers within neurons. 
Calcium influx through VDCCs is not only important in processes of mature neurons, but 
it also plays a crucial role in many developmental processes.  Calcium influx is involved 
in neuronal differentiation, growth, and maturation of developing neurons.  Interestingly, 
during the early developmental period neuronal GABAergic synaptic transmission is 
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excitatory and switches to inhibitory within the first few postnatal weeks of development 
(Ben-Ari et al., 1989; Owens et al., 1999).  The excitatory GABAergic potential can 
activate VDCCs, specifically L-type calcium channels, which results in an elevation of 
intracellular calcium concentrations (Yuste and Katz, 1991; Leinekugel et al., 1995; 
Khazipov et al., 1997).  In turn the elevated intracellular calcium concentration can 
induce an increase in brain-derived neurotrophic factor (BDNF) levels, promote neuronal 
survival and differentiation, and may be necessary to form and strengthen synaptic 
connections (Berninger et al., 1995; Ikeda et al., 1997; Kirsch and Betz, 1998; Kneussel 
and Betz, 2000). Thus, it is possible that enhancement of L-type calcium current by 
GABAB receptor activation plays an important role during the first two postnatal weeks 
in hippocampal development.   
There have only been a few studies to demonstrate facilitation of L-type calcium 
current by GABAB receptor activation (Parramόn et al., 1995; Shen and Slaughter, 1999; 
Carter and Mynlieff, 2004).  Since this phenomenon has only been demonstrated in 
hippocampal tissue isolated from neonatal rats 5 to 7 days old, it may only be present at a 
specific time point in development.  The developmental time course of L-type calcium 
current facilitation by GABAB receptor activation was determined using whole-cell patch 
clamp experiments on hippocampal cultures dissociated from neonatal rats of varying 
ages.  Neurons from the superior region of the hippocampus were isolated by a technique 
that has been well established in our laboratory (Mynlieff, 1997).  Hippocampal cultures 
prepared in our laboratory contain excitatory pyramidal cells along with several different 
types of inhibitory interneurons.  To decrease the heterogeneity of the cell cultures, only 
the superior region of the hippocampus containing the CA3 and CA1 regions was used.  
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These types of experiments are very difficult to perform using brain slices due to space 
clamp issues.  Since cultured cells are spherical for the first 24 hours in culture and do not 
contain many processes, one has better control over the currents and the environment of 
the cell.  The patch clamp technique allows for detailed analysis of ion currents and 
individual cell modulation.  For the present study, electrophysiological experiments with 
the GABAB agonist baclofen were performed on cultured hippocampal neurons obtained 
from different aged rats to identify the timecourse of L-type calcium current facilitation 
by GABAB receptor activation.  To determine if the varying baclofen responses observed 
at different developmental time points were due to changes in the number and type of 
calcium channels present, the density of HVA and LVA calcium current was measured in 
cultures obtained from different aged pups.  
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RESULTS 
Calcium Currents in Cultured Hippocampal Neurons 
 Families of calcium currents were initially recorded in experiments to characterize 
the baclofen responses in hippocampal cultures isolated from neonatal rats.  Families of 
calcium currents were elicited from a holding potential of -80 mV by 300 msec 
depolarizing test steps between -50 mV and +50 mV in 10 mV increments (Figure 3.1).  
Due to the heterogeneity of our cell cultures, each cell contains a different complement of 
calcium channels.  Therefore, there can be a wide range of activation voltages seen in 
different cells.  These values are also affected by the concentration and identity of the 
charge carrier used (Ba2+ and Ca2+).  Using 10 mM Ca2+ as the charge carrier gave 
currents that generally activated between -30 mV and -10 mV depending on the presence 
of T-type calcium channels (Figure 3.1).  The current-voltage relationship shown in 
figure 3.1B shows that from a holding potential of -80 mV, the current turns on positively 
to the -10 mV test step and peaks at +20 mV.  T-type calcium currents are activated at 
low voltages and inactivate very rapidly as can be seen in the family of currents 
represented in figure 3.1C.  The current-voltage relationship shown in figure 3.1D shows 
that from a holding potential of -80 mV, this cell appears to have two activation voltages.  
The LVA current turns on around -40 mV with the HVA component appearing around -
10 mV.  The early activation voltage is due to the presence of T-type calcium current in 
this cell.  In contrast to the cell represented in figure 3.1 C and D, the cell in figure 3.1 A 
and B, does not exhibit T-type current as demonstrated by the lack of a shoulder in the 
current-voltage relationship.   
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 Calcium current demonstrates rapid run-up or run-down of currents.  Thus, it was 
important to obtain control and baclofen data in the shortest time period possible.  To 
investigate GABAB mediated effects on HVA currents, the cells were held at -80 mV and 
100 msec
10
0 
pA
100 msec
10
0 
pA
A
C
V (mV)
-60 -40 -20 0 20 40 60
I C
a
 
(pA
)
-400
B
D
X Data
-60 -40 -20 0 20 40 60
V (mV)
IC
a 
(pA
)
-500
 
Figure 3.1: Calcium currents isolated in hippocampal neurons from 7 day old rats.  (A) and (C) 
represent families of whole cell calcium currents elicited from a holding potential of -80 with 300 
msec long depolarizing test steps from -50 mV to +50 mV in 10 mV increments.  (B) and (D) 
represent the current-voltage relationship of the total calcium current from the same cells shown 
in (A) and (C).   
 
depolarized with a 300 msec pulse to +10 mV.  This allowed for rapid measurements in 
varying conditions (control, drug, and washout) minimizing run-up or run-down.  
Calcium currents in cultured hippocampal neurons isolated from postnatal rats of varying 
ages are modulated by activation of GABAB receptors with baclofen.  Three different 
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responses are seen with baclofen application.  Calcium currents either demonstrate a 
decrease, an increase, or no change in response to GABAB receptor activation (Figure 
3.2).   
A. Decrease             B. No Change            C. Increase 
 
 
 
 
 
 
 
 
Figure 3.2: Total calcium currents were measured using whole-cell voltage clamp. The cells 
were held at -80 mV and stepped to +10 mV for 300 msec. The black trace represents the control 
current, the red trace represents when 10 µM baclofen was applied to the cell, and the blue trace 
represents the currents after baclofen was washed off of the cell.  (A) This cell illustrates 
inhibition of total calcium current in the presence of 10 µM baclofen.  (B) This cell did not show 
a response to 10 µM baclofen application.  (C) This cell shows facilitation of total calcium 
current in response to 10 µM baclofen. 
 
Time Course of Calcium Current Modulation by GABAB Receptors 
To determine whether facilitation of L-type calcium current by GABAB receptor 
activation is developmentally regulated, calcium currents were recorded in neurons 
isolated from hippocampi of 0, 3, 7, and 14 day old rat pups using whole-cell voltage 
clamp recording in the absence and presence of the GABAB agonist baclofen (10 µM).  
Currents were elicited by a 300 msec depolarizing pulse from a holding potential of -80 
mV as described in Chapter 2.  A total of 22-32 cells from each developmental time point 
studied were analyzed to determine both the percent of total cells that exhibited each 
response to baclofen application and the average magnitude of the response.  In addition, 
both the peak and sustained components of the currents were analyzed.  Measuring the 
sustained component of the current at the end of a 300 msec pulse should minimize the 
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contributions from P/Q-type and N-type calcium currents, thereby increasing the 
contribution of L-type calcium current.    
The percentage of cells demonstrating an increase, decrease, or no change in total 
calcium current depended on the age from which the neurons were isolated.  At the early 
time points more neurons demonstrated a decrease in peak calcium current in response to 
application of 10µM baclofen, while more neurons demonstrated an increase in peak 
calcium current at the later time points studied (decrease, P = 0.039; increase P < 0.001; 
using a Chi-square, Figure 3.3A).  In cultures isolated from 0 day old animals, 59.1% of 
the cells demonstrated an inhibition of peak calcium current in response to baclofen 
application.  The percentage of cells demonstrating a decrease in peak calcium current 
was not significantly different in cultures isolated from 3 day old animals (30.5%).  
However,  the percentage of cells demonstrating a decrease in peak calcium current was 
significantly lower in 7 day old animals (25%, P = 0.022, pairwise comparisons were 
determined with a Fisher’s Exact test) and 14 day old animals (25%, P = 0.035, pairwise 
comparisons were determined with a Fisher’s Exact test).  In the cells that demonstrated a 
decrease in peak calcium current from hippocampal cultures isolated from 0 day old rats, 
the average decrease in total current was 20.30 ± 2.95 % (Figure 3.3B).  The average 
percent decrease was not significantly different from the other time points studied (P = 
0.543 using an ANOVA).  In comparison to the cells demonstrating a decrease in peak 
current, more cells demonstrated an increase in peak current in response to baclofen 
application during the second postnatal week.  The percent of cells that demonstrated 
facilitation of peak calcium current is different at the various ages studied (P < 0.001 
using a Chi-square).  Only 9.1% of cells isolated from 0 day old animals and no cells 
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isolated from 3 day old rat pups demonstrated an increase in peak calcium current.  The 
percent of cells demonstrating an increase in peak calcium current was 31.3% in cultures 
isolated from 7 day old rat pups and 16.7% in cultures isolated from 14 day old rat pups.   
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Figure 3.3: Modulation of peak calcium currents by GABAB receptor activation at different 
developmental time points.  (A) Each bar represents the percentage of cells demonstrating a 
decrease, no change, or an increase in peak calcium current following application of 10 µM 
baclofen in hippocampal cultures isolated from postnatal rats ranging from 0 days to 14 days old.  
(B) Average percent decrease in peak current in cells demonstrating a decrease in response to 
baclofen (P = 0.543 using an ANOVA). 
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 Peak current is a combination of L-type, N-type, P/Q-type, R-type, and T-type 
calcium current hampering interpretation of these data.  Thus, the sustained current 
component at the end of a 300 msec depolarization pulse to +10 mV was measured 
minimizing the contribution of N-type, P/Q-type, and R-type calcium current while 
maximizing the contribution of L-type calcium current to the total measurement.  
Previous studies in the laboratory have already confirmed that the facilitatory effect of 
GABAB receptor activation on calcium currents was entirely mediated through L-type 
channels (Carter and Mynlieff, 2004).  There was not a significant difference in the 
percent of cells demonstrating facilitation of sustained calcium current in response to 
baclofen application in hippocampal cultures isolated from 0, 3, 7, or 14 day old rat pups 
when time points were analyzed separately (Figure 3.4A; P = 0.054 using a Chi-Square).  
Since the number of cells isolated from 0 and 3 day old rats responding with facilitation 
were very low and similar and the numbers of cells isolated from 7 and 14 day old rats 
responding with facilitation were much higher, the data were re-analyzed and grouped 
into early postnatal (day 0-3) and late postnatal (day 7-14) time points.  When the cells 
were grouped into early and late postnatal period, they were significantly different (P = 
0.023 using a Chi-Square).  The average percent increase in sustained calcium current in 
the cells that demonstrated an increase in calcium current with baclofen treatment were 
not significantly different at the developmental time points studied (Figure 3.4B; P = 
0.136 using an ANOVA).  The cells from 3 day old animals were not included in the 
statistical analysis, because there were only 2 cells that demonstrated an increase in 
response to baclofen.  These experiments demonstrated that the percent of cells 
demonstrating facilitation of L-type calcium current by GABAB receptor activation does 
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vary throughout the first two weeks of development and is most prominent during the 
second postnatal week.   
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Figure 3.4: GABAB receptor facilitation of sustained calcium currents at different developmental 
time points. Currents were measured at the end of a 300 msec depolarizing pulse to +10 mV from 
a holding potential of – 80 mV.  (A) Each bar represents the percent of cells demonstrating an 
increase in sustained calcium current following application of 10 µM baclofen in hippocampal 
cultures isolated from rats that were 0, 3, 7, and 14 days old ( p = 0.054 using a Chi-Square when 
each age was analyzed separately; P = 0.023 using a Chi-Square when day 0 and day 3 were 
grouped into early postnatal period and day 7 and day 14 were grouped into late postnatal period). 
(B) Average percent increase of sustained current in cells demonstrating facilitation in response 
to baclofen (P = 0.136 using an ANOVA). 
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HVA and LVA Current Densities During the First Two Postnatal Weeks 
One possible explanation for the varying baclofen responses seen at the different 
developmental ages studied could be due to changes in the number and type of channels 
present on the cell membrane.  For example, if a particular HVA current type, such as L-
type current is only modulated at earlier time points, it is possible that these channels are 
only expressed at that developmental time point.  To determine whether there are changes 
in current density, both the mean LVA and HVA current densities were measured at the 
different ages studied.  The LVA or T-type calcium current was elicited from a 300 msec 
pulse to -30 mV from a holding potential of -80 mV (Figure 3.5).  LVA current density 
was determined by dividing the peak control current in these cells by the membrane 
capacitance.  Since T-type calcium current varies throughout development, not all of the 
cells exhibited this type of current at the different time points studied (0 day (9/27), 3 day 
(9/29), 7 day (24/43) and 14 day (23/43)).  T-type current density did not significantly 
differ when cultures were isolated from rats of varying ages (P = 0.107 using an 
ANOVA). 
Figure 3.5:  T-current density in 
hippocampal neurons isolated from rat 
pups of different ages.  The low 
voltage activated T-type calcium 
current was elicited by a 300 msec 
pulse to -30 mV from a holding 
potential of -80 mV.  Only a subset of 
cells exhibited T-current in cultures 
obtained from 0 day (9/27), 3 day 
(9/29), 7 day (24/43) and 14 day 
(23/43) old rats.  The current density 
was determined by dividing the peak 
control current in these cells by the 
membrane capacitance. (P = 0.107 
using an ANOVA). 
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In addition to the LVA current density, HVA current densities were also 
determined for all of the cells studied at the different time points.  HVA currents were 
elicited with a 300 msec pulse to +10 mV from a holding potential of -80 mV (Figure 
3.6).  The peak and sustained components were separated and compared at each time 
point studied.  The peak current was measured at the beginning of the 300 msec pulse and 
the sustained current was measured at the end of the 300 msec pulse.  HVA current 
density was determined by dividing the current by the cell capacitance.  Both the peak 
and sustained current densities did not significantly change during the first two postnatal 
weeks of development in the rat hippocampus (peak, P = 0.644; sustained, P = 0.508; 
using an ANOVA).   
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Figure 3.6:  HVA current density in hippocampal neurons isolated from rat pups of different 
ages. HVA currents were elicited with a 300 msec pulse to +10 mV from a holding potential of -
80 mV. The peak current was measured at the beginning of the 300 msec pulse and the sustained 
current was measured at the end of the 300 msec pulse.  Current density was determined by 
dividing the current by the cell capacitance.  Both the peak (solid circles) and sustained (open 
circles) current densities did not significantly change during the first two postnatal weeks of 
development in the rat hippocampus (peak, P = 0.644; sustained, P = 0.508; using an ANOVA).  
The N’s ranged from 23-38 for each time point. 
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Due to the heterogeneity of our hippocampal cultures, it is possible that a cell type 
with a particular cell size or current density may demonstrate facilitation of L-type 
current by GABAB receptor activation.  To determine whether cells demonstrating an 
increase in sustained calcium current in response to baclofen application were different in 
cell size or the number and type of calcium channels present when compared to cells 
demonstrating no change or a decrease in sustained calcium current in response to 
baclofen application, cell size and HVA current densities were compared for the different 
groups of cells.  There were no significant differences in cell size (P = 0.911 using a Two 
Way ANOVA) as measured by cell capacitance or peak current density (P = 0.690 using 
a Two Way ANOVA) in the cells that exhibited an increase in sustained calcium current 
in response to 10 µM baclofen application when compared to cells that exhibited no 
effect or a decrease in sustained calcium current in response to 10 µM baclofen (Figure 
3.7).  Peak current density was determined by dividing the peak control current by the 
cell capacitance to normalize for cell size.  There was no significant difference when 
determining the current density using the sustained component (P = 0.633 using a Two 
Way ANOVA) and the transient component (P = 0.921 using a Two Way ANOVA) of 
the current (Figure 3.8). The sustained control current was measured at the end of the 300 
msec pulse and the transient component was calculated by subtracting the sustained 
current from the peak current for each cell and averaged for each group of cells.  These 
experiments demonstrated that facilitation of L-type calcium current by GABAB receptor 
activation is most prominent in neurons isolated from 7 and 14 day old rats.  However, 
the changes in response to baclofen can not be attributed to changes in HVA current 
density.   
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Figure 3.7:  Membrane capacitance and HVA current density.  (A) Membrane capacitance was 
measured as an indication of cell size.  There was not a significant difference in capacitance 
between cells that demonstrated an increase in response to 10 µM baclofen (black bars; 0 day 
(3/22), 3 day (2/23), 7 day (10/32) and 14 day (6/24)) when compared to cells that demonstrated 
no change or a decrease in response to 10 µM baclofen (gray bars) at the different time points 
studied (P = 0.911 using a Two Way ANOVA).  (B)  Total current density was determined by 
dividing the peak control current by the cell capacitance to normalize for cell size.  The average 
current densities were determined at each developmental time point for cells that exhibited an 
increase in sustained calcium current with 10 µM baclofen (black bars; 0 day (3/22), 3 day (2/23), 
7 day (10/32) and 14 day (6/24)) and cells that exhibited no change or a decrease in sustained 
calcium current with 10 µM baclofen (gray bars).  There was no difference in the average current 
densities based on the cell’s response to baclofen at the different time points studied (P = 0.690 
using a Two Way ANOVA).  
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Figure 3.8:  HVA current density.  (A) Average current densities of the sustained component of 
current prior to the application of baclofen were determined for cells that exhibited an increase in 
sustained calcium current with 10 µM baclofen (black bars; 0 day (3/22), 3 day (2/23), 7 day 
(10/32) and 14 day (6/24)) and cells that exhibited no change or a decrease in sustained calcium 
current with 10 µM baclofen (gray bars).  There were no differences in the average sustained 
current densities based on the cell’s response to baclofen at the different time points studied (P = 
0.690 using a Two Way ANOVA).  (B) There were no significant changes in the transient current 
densities between cells that exhibited an increase in sustained calcium current with 10 µM 
baclofen (black bars; 0 day (3/22), 3 day (2/23), 7 day (10/32) and 14 day (6/24)) and cells that 
exhibited no change or a decrease in sustained calcium current with 10 µM baclofen (gray bars; P 
= 0.921 using a Two Way ANOVA). 
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DISCUSSION 
 
GABAB receptors have been shown to attenuate N-type calcium current in a 
number of different cell types, including hippocampal neurons (Scholz and Miller, 1991; 
Dolphin and Scott, 1987; Mintz and Bean, 1993; Pfrieger et al., 1994; Amico et al., 1995; 
Cardozo and Bean, 1995; Lambert and Wilson, 1996; Shen and Slaughter, 1999).  N-type 
calcium channels along with P/Q-type calcium channels are concentrated in synaptic 
terminals of CNS neurons and are involved in neurotransmitter release.  N-type calcium 
channels contribute to neurotransmitter release earlier in development, whereas P/Q type 
calcium channels along with N-type calcium channels contribute to neurotransmitter 
release later in development (for review see Dolphin, 2003).  This correlates to the 
present results, which demonstrated that the inhibition of peak calcium current by 
GABAB receptors predominates in hippocampal cultures isolated from 0 day old rat pups.  
Carter and Mynlieff (2004) have demonstrated that the decrease in peak current by 
GABAB receptor activation is through N-type calcium channels.  In vivo, GABAB 
receptors involved in the inhibition of calcium current are likely to be localized on the 
presynaptic terminal providing a type of feedback inhibition of neurotransmitter release.   
Much less is known about the facilitatory actions of GABAB receptor activation 
on calcium currents.  To date, facilitation of L-type calcium current by GABAB receptor 
activation has only been observed in salamander retinal neurons (Shen and Slaughter, 
1999) in adrenal chromaffin cell cultures (Parramόn et al., 1995), and in hippocampal 
neurons (Carter and Mynlieff, 2004).  Carter and Mynlieff (2004) were the first to 
demonstrate facilitation of L-type calcium current in the mammalian CNS.  In their study, 
30% of the cells demonstrated an enhancement of calcium current in response to baclofen 
application in hippocampal cultures isolated from 5 to 7 day old rat pups.  This 
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enhancement of calcium current by GABAB receptors was blocked in the presence of the 
L-type channel blocker, nimodipine (Carter and Mynlieff, 2004).  Since this phenomenon 
has only been observed in neonates and has not been previously observed in either 
embryonic or adult hippocampal tissue, it seemed likely that the facilitation of L-type 
calcium current by GABAB receptors is only present at a specific time in development.   
The current study demonstrated that facilitation of L-type calcium current by 
GABAB receptor activation is a developmental phenomenon and is greatest in 
hippocampal cultured isolated from 7 and 14 day old rats.  When analyzing the peak 
component of the current 31% of the cells demonstrated an increase in total calcium 
current and when analyzing the sustained current component 37.5% of the cells 
demonstrated an increase in calcium current in response to baclofen application in 
hippocampal cultures isolated from 7 day old rat pups.  These percentages are consistent 
with the 30% of cells that Carter and Mynlieff (2004) found to be facilitated by GABAB 
receptor activation in hippocampal cultures isolated from 5 to 7 day old rats.  
Hippocampal cultures are heterogeneous and contain pyramidal cells along with several 
types of inhibitory interneurons.  There are over 21 distinguishable inhibitory interneuron 
subtypes that have been classified in the hippocampus based on their morphological, 
neurochemical, and electrophysiological characteristics (for review see Klausberger and 
Somogyi, 2008; Cutsuridis and Wennekers, 2009; Klausberger, 2009).  The variability in 
the responses to baclofen application is likely due to the heterogeneity of the cultures.  
Several factors such as the complement of calcium channels, the presence of GABAB1a 
versus GABAB1b receptors subtypes, the coupling with different G-proteins, the size, and 
the physical location of the cells can all vary in the different cell types present within the 
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hippocampus.  Therefore, the cells demonstrating facilitation in response to baclofen 
application could represent a specific subset of cells present in the hippocampus.   
Despite the heterogeneity of the cell cultures, experiments on HVA and LVA 
current density at various time points in this early postnatal period suggest that a global 
change in channel density or distribution of channel types in the cells cannot explain the 
differing effects of GABAB receptor activation at different time points.  The sizes of the 
cells that demonstrated facilitation were not different when compared to cells that 
demonstrated no change or a decrease in calcium current in response to baclofen 
application.  In addition, the HVA current density for cells that demonstrated facilitation 
was not different when compared to cells that demonstrated no change or a decrease in 
calcium current in response to baclofen application when the HVA current density was 
determined for the total, sustained, and transient component of the current.  These studies 
suggest that cells demonstrating facilitation of calcium current by GABAB receptors do 
not differ significantly in the size or number of channels present from cells demonstrating 
no change or a decrease in calcium current by GABAB receptors.   
Even though there are not changes in the total amount of sustained current 
throughout development, there may be variations in the contribution of the different 
forms of L-type calcium channels.  The two types of L-type calcium channels that are 
ubiquitously expressed in the brain and are present in hippocampal neurons are Cav1.2 
and Cav1.3 (Hell, 1993).  It has been demonstrated that L-type Cav1.2 protein levels peak 
in hippocampal neurons isolated from 7 day old rats (Nuñez and McCarthy, 2007), 
whereas Cav1.3 protein levels begin low and increase throughout development (Ingraham 
and Mynlieff, unpublished data).  Electrophysiological experiments in native neurons do 
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not distinguish between Cav1.2 and Cav1.3 current.  A peak facilitation of L-type calcium 
current by baclofen at approximately one week may be a reflection of the peak expression 
of Cav1.2 protein levels in these neurons.  This idea is also supported by the fact that 
immunocytochemical techniques have shown that less than 30% of hippocampal neurons 
taken from 7 day old pups demonstrate significant amounts of the Cav1.2 channels, which 
may reflect the subset of cells that demonstrate the facilitation of L-type calcium current 
by GABAB receptors. 
Our lab has demonstrated that GABAB receptor activation within the neonatal rat 
hippocampus can modulate different types of VDCCs.  Here we have demonstrated that 
the inhibitory effect predominates during the first postnatal week, while the facilitatory 
effect of calcium current by GABAB receptor activation predominates during the second 
postnatal week.  Carter and Mynlieff (2004) have demonstrated that both effects can be 
present within the same cell, which suggests different mechanisms are involved with the 
modulation of the different channel types by GABAB receptors.  L-type calcium channels 
contain several consensus phosphorylation sites for several kinases, including PKC and 
PKA, while N-type calcium channels are primarily modulated through direct interaction 
by G-proteins associated with the GABAB receptor(for review see Catterall, 2000).  The 
signal transduction mechanism involved in the facilitation of L-type current by GABAB 
receptors is an area of interest in the laboratory and will be discussed in Chapter 5.   
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CHAPTER 4 
 
 
 
 
 
 
 
 
 
 
 
The influx of calcium through L-type calcium channels is 
necessary for the upregulation of KCC2, but not NKCC1 
during development in the rat hippocampus 
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INTRODUCTION 
Early in neuronal development the neurotransmitter GABA exerts an excitatory 
rather than inhibitory effect due to a high concentration of intracellular chloride ions 
(Cherubini et al., 1991).  During the first two postnatal weeks in the hippocampus of rats 
the internal concentration of chloride ions decreases.  This causes a change in the reversal 
potential of chloride and thus, a shift from an excitatory effect of GABAA receptor 
activation to an inhibitory effect (Ben-Ari et al., 1989; Leinekugel et al., 1995, 1997, 
1998; Khazipov et al., 1997; Rivera et al., 1999; Ganguly et al., 2001).  Evidence 
suggests that the upregulation of the K+Cl- co-transporter (KCC2) and the 
downregulation of the Na+K+2Cl- co-transporter (NKCC1) are responsible for shifting the 
chloride reversal potential (Plotkin et al., 1997; Lu et al., 1999; Rivera et al., 1999; 
Hübner et al., 2001a).  NKCC1 expression predominates in immature neurons and 
mediates chloride influx, while KCC2 expression predominates in mature neurons and 
mediates chloride efflux (for review see Delpire, 2000; Payne et al., 2003).  Due to the 
high intracellular chloride concentration in immature neurons the activation of GABAA 
receptors depolarizes the cell, which subsequently activates voltage-dependent calcium 
channels, particularly L-type calcium channels (Yuste and Katz, 1991; Leinekugel et al., 
1995; Khazipov et al., 1997; Ganguly et al., 2001).  This GABAergic excitation is 
important for proper neuronal development (for review see Ben-Ari, 2002; Owens and 
Kriegstein, 2002; Fiumelli and Woodin, 2007; Galanopoulou, 2008; Kahle et al., 2008; 
Blaesse et al., 2009).  As the brain matures, the number of neurons that are excitatory in 
response to GABA decreases and thus, the magnitude of calcium influx with GABA 
receptor activation decreases.  Once neurons have fully developed, GABA responses are 
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hyperpolarizing and inhibit the cell from reaching threshold.  Additionally, the subunit 
composition of the GABAA receptor changes during development (Kanaumi et al., 2006; 
Liu and Wong-Riley, 2006; Rissman et al., 2006; Yu et al., 2006).  This change in 
subunit composition should not affect the reversal potential directly since that is 
dependent on the internal and external chloride concentrations, but it does affect the 
response to various modulators such as zinc and benzodiazepines.   
Treatment of embryonic rat hippocampal cultures with L-type calcium channel 
antagonists prohibits the shift in the chloride reversal potential, suggesting that calcium 
influx through L-type calcium channels is involved in the changes of chloride transporter 
expression (Ganguly et al., 2001).  However, Ganguly and co-workers did not directly 
look at the effect of calcium influx through L-type channels on chloride transporter 
expression.  Previous experiments in our laboratory have demonstrated facilitation of L-
type calcium current by activation of the metabotropic GABAB receptor in acutely 
cultured hippocampal neurons isolated from 5-7 day old rat pups (Carter and Mynlieff, 
2004).  The data presented in Chapter 3 suggest that the facilitation of L-type calcium 
current is maximal in the second postnatal week, a time period in which many genes 
including chloride transporters and neuronal L-type calcium channels are changing their 
expression as the neurons mature (Nuñez and McCarthy, 2007).     
The present study explores the potential connection between chloride transporter 
expression and calcium influx through L-type calcium channels in the early neonatal 
period.  Although changes in reversal potential have been shown to be dependent on 
calcium influx through L-type calcium channels, this is the first study to directly 
investigate the effect of calcium influx on the chloride transporter protein levels in 
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hippocampal neurons.  Since calcium influx is enhanced in a subset of neonatal 
hippocampal neurons by activation of GABAB receptors, activation of these receptors 
may also alter KCC2 and NKCC1 transporter expression.  The KCC2 and NKCC1 
expression levels throughout early postnatal development were determined by Western 
blot analysis in the presence and absence of an L-type channel antagonist and a GABAB 
receptor agonist. 
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RESULTS 
Developmental Regulation of NKCC1 Protein during the Early Postnatal Period 
 The expression levels of both KCC2 and NKCC1 were determined by Western 
blot analysis in hippocampal neurons cultured for various time periods and were 
compared to that from fresh tissue of equivalent ages.  KCC2 is neuron specific, whereas 
NKCC1 is expressed in neurons and also glial cells (Payne et al., 1996; Lu et al. 1999; 
Kanaka et al., 2001; Hübner et al., 2001b). Whole hippocampal tissue protein was 
isolated from rats ranging in ages 1 day to 42 days old and cultured hippocampal neurons 
that were isolated from 0 day old rat pups and kept in culture for 1 to 15 days.  Other 
investigators have demonstrated that embryonic hippocampal neurons in culture exhibit 
spontaneous activity and form synaptic connections within a few days following 
dissociation (Siebler et al., 1993; Bi and Poo, 1998; Vicario-Abejón et al., 1998).  In 
addition, postnatal cultured hippocampal neurons in the Mynlieff laboratory demonstrate 
excitatory postsynaptic currents if allowed to remain in culture for more than 24 hours 
(unpublished observations).  Anti-NKCC1 antibodies labeled a single band of 143 kDa 
on Western blots of proteins isolated from either cultured neurons or whole hippocampus 
(Figure 4.1).  Steady state NKCC1 protein levels were determined at each time point 
studied by dividing the IOD for the 143 kDa band by the IOD for a band labeled with β-
tubulin antibodies to control for variations in loading.  The internal control was necessary  
 
Figure 4.1: Using Western blot 
analysis, anti-NKCC1 antibodies label 
a single band with a molecular weight 
of 143 kDa in protein preparations 
extracted from whole hippocampus or 
cultured hippocampal neurons (right 
lane).  The left lane was loaded with 
MagicMark Western standard markers. 
NKCC1
NKCC1
238
171
117
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since the amount of protein extracted from cultured neurons was so low that the protein 
assay results were not accurate.  In contrast to KCC2 protein levels (see below), there 
was little change in the steady state protein levels of NKCC1 during the first two 
postnatal weeks of development both in fresh tissue and in cultured hippocampal neurons 
(Figure 4.2; P = 0.278 using Two Way ANOVA).  Fresh tissue that was analyzed from 
rats of one month or more in age demonstrated up to a ten-fold increase in the steady 
state expression level of NKCC1 compared to D1 protein levels (D42, 13.17 ± 4.32).   
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Figure 4.2:  Developmentally regulated expression of NKCC1 protein in rat hippocampus and 
cultured hippocampal neurons.  (A) Representative Western blot analysis of proteins extracted 
from whole hippocampus (left panel; postnatal day 1 to day 15) and cultured hippocampal 
neurons (right panel). Cultured neurons were obtained from day 0 rats and were kept in culture 
for 1 to 15 days before protein isolation (C0-1 to C0-15).  (B)  Summary data comparing the 
steady state NKCC1 protein levels isolated from whole hippocampal protein extracts (solid 
circles; N = 3) and cultured hippocampal neurons (open circles; N = 3 – 4, except C0-6 where N 
= 2).  The IOD of the band labeled with NKCC1 antibodies (143 kDa) was divided by the IOD of 
the band labeled with β-tubulin antibodies (55 kDa) for normalization.  In the first two weeks 
there was no difference in NKCC1 protein levels in the different ages across both tissue types      
(P = 0.278 using a Two Way ANOVA). 
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Developmental Regulation of KCC2 Protein during the Early Postnatal Period 
Functional KCC2 proteins form oligomers that have a molecular mass higher than 
the monomeric protein (~125 kDa).  Several studies have demonstrated KCC2 dimers 
along with monomers when performing Western blot analysis (Lu et al., 1999; Blaesse et 
al., 2006; Zhang et al., 2006).  KCC2 dimers are detected on Western blots, because they 
are resistant to both non-ionic detergents such as Triton X-100 and also the anionic 
detergent SDS (Blaesse et al., 2006).  In our study, antibodies to KCC2 labeled three 
bands of 248 kDa, 125 kDa, and 46 kDa representing a dimer, a monomer, and a splice 
variant (Figure 4.3).  As the neurons matured there were increasing amounts of the dimer 
in relation to the monomer in both whole hippocampal protein extracts as well as cultured 
protein extracts.  Steady state KCC2 protein levels were determined at each time point 
studied by adding the IOD for the band corresponding to the monomer plus the IOD for 
the band corresponding to the dimer and this value was further divided by the IOD for a 
band labeled with β-actin antibodies as a control for variations in loading.  Since the 
intensity of the band corresponding to the KCC2 splice variant was a minor component in 
most preparations and the fact that the splice variant is not considered as an active form 
of the KCC2 protein, it was not included in the data analysis.  Previous studies showed 
that KCC2 mRNA levels within the rat hippocampus are low following birth and rapidly  
 
Figure 4.3: This sample Western blot 
demonstrates the three bands labeled 
with anti-KCC2 antibodies with 
molecular weights of 248 kDa, 125 
kDa, and 46kDa in protein preparations 
extracted from whole hippocampus or 
cultured hippocampal neurons (right 
lane). The left lane was loaded with 
MagicMark Western standard markers. 
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rise in the first few postnatal weeks (Rivera et al., 1999; Balakrishnan et al., 2003).  Our 
protein data is consistent with the mRNA data in that both fresh tissue and cultured 
neurons demonstrated low KCC2 protein levels during the first postnatal week, but levels 
rapidly rise during the second postnatal week ((Figure 4.4; P < 0.001 using a Two Way 
ANOVA).  In fresh tissue the protein level tripled between day 15 and day 24 (D24, 11.86 
± 4.2), at which point it plateaued through adulthood (D33, 9.31 ± 0.66; D42 9.60 ± 
2.76).  The increase in KCC2 protein levels during the second postnatal week in 
development occurred both in vivo and in cultured hippocampal cells, supporting the use 
of cultured hippocampal neurons to study the developmental expression of KCC2.  In 
addition, the results presented in Chapter 3 demonstrate that in hippocampal cell cultures 
obtained from rats of various ages L-type current facilitation peaks at approximately the 
same developmental time point as KCC2 expression levels begin to rise.  This supports 
the hypothesis that facilitation of L-type calcium current by GABAB receptor activation 
within the hippocampus may play a role in the regulation of KCC2 during the first two 
postnatal weeks of development. 
 Other investigators have demonstrated that the internal chloride concentration 
decreases during the early postnatal period in rat hippocampal neurons.  This could be 
due to a concurrent increase in KCC2 with a decrease in NKCC1, since these transporters 
move chloride in the opposite direction.  However, our data suggest that only the KCC2 
transporter levels are changing in the first two postnatal weeks of hippocampal 
development and that it is the ratio of the two transporters that is important in 
determining the intracellular concentration of chloride and thus, the reversal potential for 
 73
 
 
the GABAA response.  Our data demonstrate a large increase in the KCC2 to NKCC1 
ratio between postnatal day 8 and 12 (Figure 4.5; P = 0.005 using an ANOVA). 
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Figure 4.4:  Developmentally regulated expression of KCC2 protein in rat hippocampus and 
cultured hippocampal neurons.  (A) Representative Western blot analysis of proteins extracted 
from whole hippocampus (left panel; postnatal day 1 to day 15) and cultured hippocampal 
neurons (right panel). Cultured neurons were obtained from day 0 rats and were kept in culture 
for 1 to 15 days before protein isolation (C0-1 to C0-15).  (B)  Summary data comparing the 
steady state KCC2 protein levels isolated from whole hippocampal protein extracts (solid circles; 
N = 3) and cultured hippocampal neurons (open circles; N = 3 – 4, except C0-6 where N = 2).  
The IOD of the band corresponding to the monomer (125 kDa) and the IOD of the band 
corresponding to the dimer (248 kDa) were added together and divided by the IOD for the band 
labeled with β-actin antibodies (45 kDa).  There is a significant difference in KCC2 protein levels 
at the different ages across both tissue types (P < 0.001 using a Two Way ANOVA).   
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Figure 4.5:  KCC2 to NKCC1 
ratio.  The ratio of KCC2 to 
NKCC1 was determined using the 
normalized values for the cultured 
hippocampal neurons for each date 
that a preparation was isolated.  
An average of three to four 
preparations was determined for 
each time point.  The ratio of 
KCC2 to NKCC1 is higher at 12 
and 15 days in culture (P = 0.005 
using an ANOVA). 
 
 
Role of L-type Calcium Channels and GABAB Receptors in Modulating Chloride 
Transporter Expression 
To determine whether calcium influx through L-type calcium channels and 
GABAB receptor activation affect the protein level of KCC2 and NKCC1 during the early 
neonatal period, hippocampal cultures isolated from 0 day rats were treated daily with the 
GABAB receptor agonist baclofen (10 µM) or the L-type calcium channel antagonist 
nimodipine (5 µM) for one week.  Previous studies treating cultures with the vehicles for 
these drugs demonstrated only a small shift in pH (<0.1) and no effect on cell viability or 
protein levels (data not shown).  Steady state NKCC1 protein levels were determined by 
Western blot analysis and the values were determined by dividing the IOD for the band 
corresponding to NKCC1 by the IOD for a band corresponding to β-tubulin.  This value 
was further normalized by dividing it by the value obtained for the control culture grown 
in the absence of any drugs along side each set of cultures treated with drugs and exposed 
to the same film and multiplied by 100%.  NKCC1 protein levels during the first 
postnatal week were not modified by treatment with the GABAB agonist baclofen 
(101.50 ± 8.90%; N = 4 individual cultures, P = 0.8772 using a one sample t-test; Figure 
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4.6A).  In addition, the L-type calcium channel antagonist nimodipine did not affect the 
steady state protein levels of NKCC1 during the first postnatal week of development 
(93.50 ± 6.90%; N = 4 individual cultures, P = 0.4177 using a one sample t-test; Figure 
4.6A).  Therefore, NKCC1 protein levels in hippocampal cultures are not affected by one 
week treatment of the GABAB agonist, baclofen or the L-type antagonist, nimodipine.   
Steady state KCC2 levels were analyzed by Western blot and the values were 
determined by adding the IOD for the band corresponding to the monomer plus the IOD 
of the band corresponding to the dimer and dividing it by the IOD for a band labeled by 
β-actin antibodies.  This value was further normalized by dividing it by the normalized 
IOD obtained from the control culture that was run on the same gel and exposed to the 
same film and multiplied by 100%.  A total of 8 cultures were treated with each drug.  
The steady state protein levels of KCC2 after a week in culture were not significantly 
altered by treatment with the GABAB agonist baclofen (108.38 ± 12.03%; N = 8, P = 
0.5357 using a one sample t-test; Figure 4.6B).  The steady state protein levels of KCC2 
were greatly reduced by treatment with the L-type calcium channel antagonist 
nimodipine (46.38 ± 5.37%; N = 8, P = 0.0001 using a one sample t-test; Figure 4.6B).  
Thus, the upregulation of steady state KCC2 expression that normally occurs during the 
first postnatal week in culture appears to be dependent, at least in part, on calcium influx 
through L-type channels.   
In addition to baclofen and nimodipine, a small number of cultures were also 
treated with 10 µM 2-OH-saclofen, a GABAB antagonist.  2-OH-saclofen (10 µM) did 
not affect the protein levels of KCC2 during the first postnatal week in culture (data not 
shown).  These results were similar to the data collected from cultures treated with the 
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GABAB agonist baclofen, which also did not affect KCC2 protein levels during the first 
postnatal week in culture.   Therefore, additional experiments were not performed using 
the GABAB antagonist 2-OH-saclofen.   
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Figure 4.6:  Effects of baclofen and nimodipine on chloride transporter expression using Western 
blot analysis. Hippocampal cultures were obtained from day 0 rats and either 10 µM baclofen, a 
GABAB agonist, or 5 µM nimodipine, an L-type calcium channel antagonist were added daily to 
the cultures for one week.  Each bar represents one protein preparation that was isolated from a 
set of cultures treated with either drug and an average (hatched bar) was determined for both drug 
treatments.  (A) NKCC1 steady state protein levels following treatment with a GABAB agonist or 
an L-type calcium channel antagonist.  The IOD of the band labeled with NKCC1 antibodies was 
divided by the IOD of the band labeled with β-tubulin antibodies.  This value was further 
normalized by dividing it by the value obtained for the control culture for each set of cultures and 
multiplied by 100%.  (B) KCC2 steady state protein levels following treatment with a GABAB 
agonist or an L-type calcium channel antagonist.  The IOD of the band corresponding to the 
monomer and the IOD of the band corresponding to the dimer of KCC2 were added together and 
divided by the IOD of the band labeled with β-actin antibodies.  This value was further 
normalized by dividing it by the value obtained for the control culture for each set of cultures and 
multiplied by 100%.  (*P = 0.0001 using a one sample t-test). 
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DISCUSSION 
 GABA is the main inhibitory neurotransmitter within the adult brain.  However, 
activation of GABAA receptors has an excitatory effect in immature neurons due to the 
high intracellular chloride levels (Cherubini et al., 1991).  Later in development the 
activation of GABAA receptors has an inhibitory effect that persists into adulthood. 
Changes in chloride transporter expression levels during the first few postnatal weeks of 
development are thought to underlie this developmental switch (Plotkin et al., 1997; Lu et 
al., 1999; Rivera et al., 1999; Hübner et al., 2001a).  The mechanisms involved in 
signaling the shift in transporter expression are not known.  It has been demonstrated that 
blockade of GABAA receptors or L-type calcium channels delays the change in the 
reversal potential of chloride in developing hippocampal neurons (Ganguly et al., 2001). 
Prior to the switch in reversal potential for the GABAA receptor, activation of these 
receptors causes calcium influx through VDCCs due to the depolarizing nature of the 
response.  These data from Ganguly and co-workers (2001) suggest that L-type calcium 
current may play a role in the changes in chloride transporter expression that occurs in 
the rat hippocampus during the first two postnatal weeks of development.  Our laboratory 
has demonstrated that activation of the GABAB metabotropic receptor can enhance 
calcium influx through L-type calcium channels and attenuate calcium influx through N-
type calcium channels during the early neonatal period (Carter and Mynlieff, 2004).  The 
attenuation of N-type calcium current by GABAB receptors is known to persist into 
adulthood in the hippocampus and is likely to modulate neurotransmitter release from the 
presynaptic terminal (Dutar and Nicoll, 1988; Harrison, 1990; Lambert et al., 1991; 
Thompson and Gähwiler, 1992; Davies and Collingridge, 1993; Pfrieger et al., 1994; Wu 
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and Saggau, 1995).  The functional role of L-type calcium channel enhancement is less 
clear.  The present study demonstrated that influx of calcium through L-type calcium 
channels is necessary for the upregulation of KCC2 protein levels in the first postnatal 
week within the hippocampus.  Thus, these findings support the hypothesis that calcium 
influx through L-type channels is involved in the developmental switch of the GABAA 
response by affecting chloride transporter expression.  
Several investigators have described conflicting expression patterns of NKCC1 
throughout hippocampal development.  Therefore, it was necessary to perform a 
timecourse of NKCC1 protein level changes in cultured hippocampal neurons.  Our 
developmental timecourse of NKCC1 protein levels is consistent with previous studies 
looking at NKCC1 mRNA and protein within rat hippocampal neurons (Yan et al., 2001; 
Wang et al., 2002).  These studies observed an upregulation of both NKCC1 mRNA and 
protein in the developing rat hippocampus with a peak level of expression within the 
adult.  The Western blot analysis of NKCC1 by Yan et al. (2001) demonstrated a trend 
for an increase in the first three postnatal weeks but only in the adult was the increase 
statistically significant, which is very similar to the data presented here.  The preparations 
from fresh hippocampal protein also contain glial cells, which are one of the main cell 
types that express NKCC1 protein in adult hippocampus (Kanaka et al., 2001; Yan et al., 
2001; Wang et al., 2002).  The fact that whole hippocampal preparations contain glial 
cells could explain why NKCC1 protein expression levels are higher in the preparations 
isolated from adult tissue versus tissue isolated from neonates. However, some studies 
have seen peak expression of NKCC1 mRNA and protein within the rat hippocampus at 
postnatal day 7 with very little expression in the adult (Plotkin et al., 1997).  Our cultures 
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are strictly neuronal and do not support glial cells (Mynlieff, 1997).  Fresh tissue 
consistently demonstrated higher NKCC1 levels than age matched cultures, which is 
likely due to the lack of glial cells in the cultures.  Therefore, all NKCC1 protein levels 
measured in culture reflect expression within the first two postnatal weeks exclusively in 
neurons.   
In whole hippocampal protein extracts from 1, 4, and 6 day old rats and in 
cultures isolated on day 0 and kept in culture for 1, 4, and 6 days, KCC2 protein levels 
remain relatively low.  However, in fresh hippocampal extracts as well as in cells kept in 
culture, the slope of the KCC2 protein levels drastically increases between day 6 and day 
8, correlating well with the peak in the enhancement of L-type calcium current by 
GABAB receptor activation during the second postnatal week (Figure 4.7).  KCC2 protein 
levels continue to rise throughout the first few weeks of development and plateau by 
three weeks of age.  This trend in KCC2 expression in vivo was similar to what was seen 
in our cultured hippocampal neurons as well as by others studying expression of KCC2 
by Western blot analysis or mRNA levels (Rivera et al., 1999; Lu et al., 1999; Wang et 
al., 2002; Stein et al., 2004; Nuñez and McCarthy, 2007).  The fact that there are not 
dramatic changes in NKCC1 transporter protein levels during the first two postnatal 
weeks suggest that the ratio of KCC2 to NKCC1, versus the downregulation of NKCC1 
protein levels may be responsible for the change in the reversal potential of chloride and 
thus, the developmental switch of the GABAA response from excitatory to inhibitory.   
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Figure 4.7 Comparison of cell percentage demonstrating L-type current 
facilitation and KCC2 steady state levels in whole hippocampal protein extracts. 
The bar graph represents the percent of cells that exhibited L-type calcium 
current facilitation in response to GABAB receptor activation at different 
developmental ages.  The line graph represents the steady state KCC2 levels in 
whole hippocampal protein extracts determined by Western blot analysis.   
 
NKCC1 expression in hippocampal cultures was not affected by either baclofen 
or nimodipine treatment. While these data suggest that neither GABAB receptor 
activation nor L-type calcium current is directly involved in developmental changes of 
NKCC1 protein levels, the involvement of L-type calcium current in KCC2 expression 
would still cause a change in the KCC2/NKCC1 ratio.  Ultimately, it is the ratio of these 
two transporters that determines the internal chloride concentration since they carry 
chloride in opposite directions.  Thus, a change in just one transporter will alter the ratio 
and affect the chloride reversal potential.  Relatively little change in the NKCC1 protein 
levels during the first two weeks in culture is offset by the large increase in KCC2 protein 
levels.  
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Treatment of hippocampal cultures with the L-type calcium channel blocker 
nimodipine significantly blocked the upregulation of KCC2 protein levels compared to 
the cultures not treated with the blocker.  Calcium influx through L-type calcium 
channels appears necessary to signal a pathway involved in the upregulation of KCC2.  
These findings support the model that the elevation of intracellular calcium levels 
through VDCCs promotes the developmental switch of the GABAA response from 
excitatory to inhibitory.  This role of L-type calcium channels in regulating KCC2 protein 
levels also suggests that L-type calcium current facilitation by GABAB receptor 
activation could enhance the upregulation of KCC2 during the early neonatal period 
within the rat hippocampus.  However, when cultures were treated with the GABAB 
agonist baclofen there was no significant change in KCC2 protein levels compared to the 
untreated cultures.  There are a number of reasons that enhancement of L-type calcium 
current by activation of GABAB receptors may be important in this developmental switch 
without demonstrating an effect in the current study.  Typically, only about 30% of the 
neurons demonstrate an enhancement of the L-type calcium current with GABAB 
receptor activation. The effect of baclofen may have been quite significant on the KCC2 
expression in these individual cells, but when the tissue was pooled for a Western blot 
analysis it would not be sufficient to see a significant change in the protein levels.  
Ideally, one would need to perform experiments such as single cell RT-PCR to determine 
if the chloride transporters are affected by GABAB receptor activation differently in 
distinct cells.  In addition, there is still a large amount of L-type calcium current in the 
absence of GABAB receptor activation.  The activation of the GABAB receptors merely 
“enhances” the whole cell current that is already present.  To see a difference in protein 
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levels by Western blot analysis one needs a very robust change such as that seen with 
nimodipine.  Perhaps the “enhancement” seen with baclofen was not sufficiently large to 
analyzed by this method.   
In conclusion, the activation of VDCCs following depolarizing GABAA responses 
aids in signaling the developmental switch of the GABAA response from excitatory to 
inhibitory.  Here we have demonstrated that L-type calcium current plays a role in the 
upregulation of KCC2 protein levels during the first few weeks of hippocampal 
development without causing a significant change in the NKCC1 protein levels.  
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CHAPTER 5 
 
 
 
 
 
 
 
 
 
 
 
 
The signal transduction mechanism of L-type calcium current 
facilitation by GABAB receptor activation in the  
neonatal rat hippocampus 
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INTRODUCTION 
The regulation of N-type as well as P/Q-type calcium channels has been well 
studied in neurons.  Less is known about the regulation of L-type calcium channels in 
neurons.  L-type calcium channels play a large role in the function of both cardiac and 
skeletal muscle.  Thus, many investigators have concentrated on studying the regulation 
of L-type calcium channels in muscle tissue, particularly cardiac muscle.  Neuronal 
activity is commonly regulated by GABA, which can activate metabotropic GABAB 
receptors.  Upon GABAB receptor activation, neuronal calcium channels can be directly 
regulated by either Gα or Gβγ subunits or they can be indirectly regulated by G proteins 
through second messenger systems (for review see Catterall, 2000; Dolphin, 2003; 
Tedford and Zamponi, 2006).   
It has been demonstrated that GABAB receptors predominantly couple to Gi/o 
proteins (Morishita et al., 1990; Campbell et al., 1993; Menon-Johansson et al., 1993; 
Greif et al., 2000).  One of the most common mechanisms of channel modulation by 
GABAB receptor activation occurs through direct modulation by Gβγ subunits associated 
with Gαi/o proteins (for review see Bettler et al., 2004).  In the hippocampus, inhibition of 
N-type and P/Q-type calcium channels by presynaptic GABAB receptor activation occurs 
through direct modulation by Gβγ subunits (Kajikawa et al., 2001).  Binding of Gβγ 
subunits to the channel inhibits its activity by making it more difficult for the channel to 
open (Bean, 1989b; Boland and Bean, 1993; Herlitze et al., 1996; Ikeda, 1996; Zamponi 
and Snutch, 1998; Colecraft et al., 2000).  GIRK channels are directly activated by Gβγ 
subunits associated with Gαi/o proteins coupled to GABAB receptors.  GIRK channels can 
also be modulated through kinase activity.  PKA increases the activation of GIRK 
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channels, whereas PKC decreases the activation of GIRK channels (for review see Luján 
et al., 2009).   
 Previous experiments have demonstrated that GABAB receptor activation can lead 
to an attenuation of N-type calcium current and the enhancement of L-type calcium 
current in hippocampal cultures obtained from neonatal rat pups of various ages (Carter 
and Mynlieff, 2004; Bray and Mynlieff, 2009).  It is well known that the inhibition of N-
type calcium current by GABAB receptor activation is mediated by a G-protein from the 
Gi/o protein family, which are sensitive to PTX.  However, the signal transduction 
pathway involved in the facilitation of L-type current by GABAB receptors in mammalian 
neurons is unknown.   
In addition to direct modulation by Gβγ, activation of G-proteins can also lead to 
activation of kinases, which can modulate calcium channel activity as well.  L-type 
calcium channels have several consensus sites for phosphorylation by PKC and PKA.  
PKC is typically activated through the Gαq/11 pathway and PLC.  PKA activation is 
dependent on the presence of cAMP.  The levels of cAMP are determined by adenylyl 
cyclase activity, which can either be stimulated by Gαs or inhibited by Gαi.  GABAB 
receptor activation of PKC and PKA has been shown to facilitate L-type calcium current 
in a subset of salamander retinal neurons (Shen and Slaughter, 1999).  It has been 
demonstrated specifically within the rat hippocampus, that activation of PKC can 
facilitate L-type calcium current (Doerner and Alger, 1992).  However, this response was 
not directly linked to GABAB receptors.   
This study was designed to elucidate the signal transduction mechanism of 
GABAB receptor modulation of L-type calcium channels within the neonatal rat 
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hippocampus.  Although activation of PKC has been shown to enhance L-type calcium 
current within the hippocampus, this is the first study to directly investigate the potential 
role of PKC in GABAB receptor mediated facilitation of L-type calcium current.  
Electrophysiological experiments were performed on cultured hippocampal neurons in 
the presence and absence of several PKC and PKA antagonists, as well as agonists for 
both types of kinases to determine their involvement in the signaling pathway of GABAB 
receptor activation and the subsequent enhancement of L-type calcium current.  Calcium 
current facilitation in response to baclofen application has been shown to be most 
prominent in hippocampal cultures isolated from 7 and 14 day rat pups.  Therefore, all 
hippocampal cultures used in these experiments were isolated from rat pups that were 6 
to 8 days old in order to maximize the number of cells exhibiting the facilitatory 
response.    
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RESULTS 
Since one of the most common mechanisms of channel modulation by GABAB 
receptor activation occurs through direct modulation by a Gi/o protein, the first 
experiment performed was overnight treatment of hippocampal cultures obtained from 7 
day old rat pups with PTX (200 ng/ml).  PTX was added to the cultures two hours after 
dissociation.  Addition of PTX inactivates Gi/o proteins by ADP-ribosylation.  As 
described in Chapter 2, calcium currents were elicited by a 300 msec depolarizing pulse 
to +10 mV from a holding potential of -80 mV (Figure 5.1).  The distribution of the  
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Figure 5.1 Calcium currents in the presence of PTX.  Calcium currents were elicited by a 300 
msec depolarization to +10 mV from a holding potential of -80 mV.  The peak current is 
measured at the beginning of the 300 msec pulse.  The black trace represents the control current, 
the red trace represents when 10 µM baclofen was applied to the cell, and the blue trace 
represents the currents after baclofen was washed off of the cell. The cell represented in A and B 
did not show an effect to baclofen application in the presence of PTX, whereas the cell 
represented in C and D demonstrated facilitation of peak calcium current in response to baclofen 
application in the presence of PTX.  
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responses differed in cultures that were treated with PTX in comparison to non-treated 
cultures (P = 0.009 using a Chi-square).  In cultures that were not treated with PTX, 
33.33% of cells demonstrated a decrease, 38.46% of cells demonstrated no change, and 
28.21% of cells demonstrated an increase in peak calcium current in response to 10 µM 
baclofen.  In cultures that were treated with PTX, no cells demonstrated a decrease, 70% 
of cells demonstrated no change, and 30% of cells demonstrated an increase in peak 
calcium current in response to 10 µM baclofen.  Facilitation of calcium current in 
response to 10 µM baclofen was still seen in cells treated with PTX, which suggests that 
facilitation of L-type calcium current is not mediated by a PTX sensitive G-protein 
(Figure 5.2).  However, it was demonstrated that the inhibition of N-type calcium current 
by GABAB receptors in the neonatal rat hippocampus is mediated through a Gi/o protein, 
because following PTX treatment no cells demonstrated inhibition of their current (P = 
0.002 using a Fisher’s Exact test for pairwise comparisons).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Effect of PTX on the baclofen responses in hippocampal neurons.  The peak 
component of calcium current was measured at the beginning of a 300 msec depolarizing pulse to 
+10 mV from a holding potential of -80 mV.  Cells were classified as demonstrating a decrease 
(black bar), no change (light gray bar), or an increase (dark gray bar) in response to 10 µM 
baclofen.  Data were collected from 39 control cells and 20 cells in the presence of PTX (200 
ng/ml, P = 0.009 using a Chi-square).  Pairwise comparisons were done with a Fisher’s Exact 
Test.  * indicates a statistically significant difference.   
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PKC Inhibitors Block the Ability of Baclofen to Facilitate Sustained Current 
 
 The goal of these experiments was to determine whether or not PKC was involved 
in the signal transduction pathway of L-type calcium current facilitation by GABAB 
receptors.  Although over 12 different isoforms of PKC have been classified, broad-
spectrum PKC inhibitors were used as a first step in determining the involvement of PKC 
in the signal transduction pathway of the facilitatory response by GABAB receptor 
activation.  Several PKC inhibitors with different chemical structures were used for 
verification of the results.  Each of the inhibitors used has been shown to be a potent and 
selective inhibitor of PKC (Table 5).   
Table 5. The PKC inhibitors used were selective for several PKC isoforms. 
The first PKC inhibitor tested was the PKC fragment 19-36, which corresponds to 
a conserved region of the regulatory domain of PKC.  This synthetic peptide fragment 
has been shown to inhibit both autophosphorylation and substrate phosphorylation of 
PKC by acting as a potent substrate antagonist (House and Kemp, 1987).  This peptide 
was shown to block the facilitation of L-type calcium current by GABAB receptors in 
salamander retinal cells (Shen and Slaughter, 1999).  Since the PKC fragment 19-36 is 
not membrane permeable, it was included in the internal pipette solution.  For all PKC 
and PKA antagonists and agonists, the sustained component of the current was analyzed 
to maximize the contribution of L-type calcium current.  It is well documented that 
PKC Inhibitors PKC Isoforms References 
PKC Fragment 19-36 All isoforms House and Kemp, 1987 
GF-109203X α, β1, βII, δ, ε, ζ, γ Toullec et al., 1991;  Martiny-Baron et al., 1993 
Chelerythrine Chloride Group A and Group B (α, βI, βII, γ) (δ, ε, ζ, η) Herbert et al., 1990 
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voltage-dependent calcium currents run down or run up in recordings made from cultured 
cells, which makes the ability to hold a cell through numerous drug applications and 
washes limited.  Therefore, all experiments with kinase inhibitors and activators were 
carried out as population studies, comparing the distribution of responses in the presence 
and absence of each compound tested.  In addition to the comparison of the percent of 
cells demonstrating each response to baclofen application, the average percent change in 
the magnitude of sustained current was also compared back to the average percent change 
seen in hippocampal cultures isolated from 6 to 8 day old rats that were treated with 
baclofen in the absence of any kinase inhibitors or activators (Figure 5.3). 
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Figure 5.3:  Summary of the average percent change in sustained calcium current in 
response to 10 µM baclofen in control cells isolated from postnatal rats 6 to 8 days old.  
Each bar represents the mean percent change of sustained calcium current. Cells were 
classified as demonstrating a decrease (black bar), no change (light gray bar), or an 
increase (dark gray bar) in response to 10 µM baclofen.   
 
The distribution of the responses differed in the presence of the PKC fragment 19-
36 in comparison to the control cells (Figure 5.4; P = 0.003 using a Chi-square).  In 
control cultures 34.1% of cells demonstrated a decrease in sustained calcium current, 
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29.5% of cells demonstrated no change in sustained calcium current, and 36.4% 
demonstrated an increase in sustained calcium current in response to 10 µM baclofen.  
When the PKC fragment 19-36 (2 µM) was included in the recording pipette, 28.6% of 
cells demonstrated a decrease in sustained calcium current, 60.7% of cells demonstrated 
no change in sustained calcium current, and 10.7% of cells demonstrated an increase in 
sustained calcium current in response to 10 µM baclofen (P = 0.027 using a Fisher’s 
exact test for pairwise comparisons).  Data using the PKC pseudosubstrate peptide 
inhibitor, PKC fragment 19-36, suggest that PKC may be involved in the signaling 
pathway of L-type calcium current facilitation by GABAB receptors.   
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Figure 5.4: Effect of the PKC inhibitors, PKC fragment 19-36, GF-109203X, and chelerythrine 
chloride on the baclofen responses in hippocampal neurons.  The sustained component of calcium 
current was measured at the end of a 300 msec depolarizing pulse to +10 mV from a holding 
potential of -80 mV.  Cells were classified as demonstrating a decrease (black bar), no change 
(light gray bar), or an increase (dark gray bar) in sustained calcium current in response to 10 µM 
baclofen.  Data were collected from 44 control cells, 28 cells in the presence of the PKC fragment 
19-36 (2 µM), 28 cells in the presence of GF-109203X (500 nM), and 25 cells in the presence of 
chelerythrine chloride (5 µM). P = 0.003 using a Chi-square when comparing all of the groups 
together. Pairwise comparisons were done with a Fisher’s Exact Test.  * indicates a statistically 
significant difference.   
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 The PKC inhibitor, GF 109203X (also known as bisindolylmaleimide I and Gö 
6850) was also used to determine the involvement of PKC in the signal transduction 
pathway of GABAB receptor facilitation of L-type calcium current.  This inhibitor was 
used by Shen and Slaughter (1999) to demonstrate the involvement of PKC in the signal 
transduction pathway of GABAB receptor facilitation of L-type calcium current in 
salamander retinal neurons.  GF-109203X is a competitive inhibitor for ATP binding and 
is highly selective for PKC when compared to several different protein kinases (Toullec 
et al., 1991; Martiny-Baron et al., 1993).  GF-109203X has been shown to inhibit several 
PKC isoforms in tissue from rat brain including α, βI, ε, δ, and ζ (Martiny-Baron et al., 
1993) and α, βI, βII, and γ in bovine brain tissue (Table 5; Toullec et al., 1991).  In the 
study by Toullec and others (1991) GF-109203 inhibited all of the four PKC isoforms 
tested (α, βI, βII, and γ) with similar potency, whereas Matiny-Baron and others (1993) 
saw inhibition with a ranked order of potency (α > βI > ε > δ > ζ).   
Since GF-109203X is membrane permeable, the compound was included in both 
the external bath calcium solution and in the baclofen solution.  The distribution of the 
responses differed in the presence of GF-109203X (500 nM) in comparison to the control 
cells (P = 0.003 using a Chi-square).  When GF-109203X (500 nM) was present 46.4% 
of the cells demonstrated a decrease in sustained calcium current, 50.0% of cells 
demonstrated no change in sustained calcium current, and 3.6% of cells demonstrated an 
increase in sustained calcium current in response to 10 µM baclofen (Figure 5.4).  
Focusing on the facilitatory response, 36.4% of the control cells demonstrated facilitation 
of sustained calcium current when treated with 10 µM baclofen, while only 3.6% of cells 
demonstrated facilitation of sustained calcium current treated with 10 µM baclofen when 
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GF-109203X was included in the external recording solution (P = 0.001 using a Fisher’s 
exact test for pairwise comaprison).  Only a single cell out of the 28 cells recorded from 
demonstrated a 7.51% increase in sustained calcium current with baclofen application 
when GF-109203X (500 nM) was included in the recording solutions, which is lower 
than the average percent increase for the 16 control cells demonstrating facilitation (18.07 
± 2.78%, Figure 5.3).  
The last PKC inhibitor used to confirm the involvement of PKC in the signal 
transduction pathway of GABAB receptor facilitation of L-type calcium current was 
chelerythrine chloride.  Chelerythrine chloride is a benzophenanthridine alkaloid that 
inhibits PKC by interacting with the catalytic domain (Herbert et al., 1990).  This 
compound has also been shown to affect PKC translocation from the cytosol to the 
plasma membrane (Chao et al., 1998).  Chelerythrine chloride is a selective inhibitor of 
the conventional PKC isoforms (α, βI, βII, and γ) as well as several of the novel PKC 
isoforms and atypical PKC isoforms (Herbert et al., 1990; Liu et al., 1994; Chmura et al., 
2000; Siomboing et al., 2001).  Chelerythrine chloride is membrane permeable and 
therefore was included in both the external calcium solution and in the baclofen solution.  
The distribution of the responses differed in the presence of chelerythrine chloride (5 µM) 
in comparison to the control cells (P = 0.003 using a Chi-square).   When chelerythrine 
chloride was present in the recording solutions, 12.0% of the cells demonstrated a 
decrease in sustained calcium current, 80.0% of cells demonstrated no change in 
sustained calcium current, and 8.0% of cells demonstrated an increase in sustained 
calcium current in response to 10 µM baclofen (Figure 5.4; P = 0.011 using a Fisher’s 
exact test for pairwise comparisons).  The 2 cells demonstrating facilitation of sustained 
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calcium current when treated with 10 µM baclofen in the presence of chelerythrine 
chloride exhibited an average percent increase of 9.46%, which is lower than the average 
percent increase of the 16 control cells that demonstrated facilitation in response to 10 
µM baclofen (18.07 ± 2.78%, Figure 5.3).   
All three of the PKC inhibitors used, PKC fragment 19-36, GF-109203X, and 
chelerythrine chloride blocked the ability of baclofen to facilitate sustained calcium 
current in response to baclofen application.  These data all support the hypothesis that 
PKC is involved in the pathway of facilitation of L-type calcium current by GABAB 
receptor activation.  However, PKC inhibition did not block the ability of baclofen to 
decrease sustained calcium current, supporting the hypothesis that the decrease of N-type 
calcium current by GABAB receptor activation occurs though a different signal 
transduction mechanism and is not mediated by PKC.   
 
Activation of PKC by PMA Mimics the Effect of Baclofen to Facilitate Sustained 
Current 
 
If a novel or conventional PKC isoform is involved in the signal transduction 
pathway of L-type calcium current facilitation by GABAB receptors, activation of PKC 
with a phorbol ester should mimic the facilitatory response seen with baclofen 
application.  Like diacylglycerols, phorbol esters activate PKC by binding to the C1 
domain of the PKC regulatory region (Burns and Bell, 1991).  PMA is a non-selective, 
general PKC activator and has been shown to activate both the conventional and novel 
PKC isoforms, but not the atypical PKC isoforms (Riedel et al., 1993a, 1993b; Goode et 
al., 1994; Shieh et al., 1995, 1996).  PMA was applied to the cells the same way baclofen 
was applied as described in Chapter 2 using a U-tube delivery system made out of PE-10 
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polyethylene tubing housed in a plexiglass arm.  The distribution of the responses 
differed when PMA was applied to the cells (1 µM) in comparison to the control cells 
where 10 µM baclofen was applied (P = 0.003 using a Chi-square).  As seen with 
baclofen application, a third of the cells (30.80%) demonstrated facilitation of sustained 
calcium current when 1 µM PMA was applied to hippocampal cultures isolated from rat 
pups that were 6 to 8 days old (Figure 5.5).  The average percent increase of the 8 cells  
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Figure 5.5: Effect of the PKC activator PMA on the baclofen responses in hippocampal neurons.  
The sustained component of calcium current was measured at the end of a 300 msec depolarizing 
pulse to +10 mV from a holding potential of -80 mV.  Cells were classified as demonstrating a 
decrease (black bar), no change (light gray bar), or an increase (dark gray bar) in response to 10 
µM baclofen or 1 µM PMA.  Data were collected from 44 cells with baclofen and 26 cells with 
PMA application (P = 0.003 using a Chi-square).  Pairwise comparisons were done with a 
Fisher’s Exact Test.  * indicates a statistically significant difference.   
 
that demonstrated facilitation of sustained calcium current in response to PMA 
application was 20.11 ± 2.7%, which is consistent with the 16 control cells that 
demonstrated an 18.07 ± 2.78 % increase with 10 µM baclofen application (Figure 5.2).   
Only a single cell demonstrated a decrease (8.74%) in response to PMA application, 
which further suggests that the decrease of calcium current in response to GABAB 
 96
 
 
receptor activation is not through a PKC mediated pathway.  This experiment using the 
PKC activator PMA supports the hypothesis that PKC is involved in the signal 
transduction mechanism of L-type calcium current facilitation by GABAB receptors.   
 
PKA inhibitors had varying effects on the facilitation of L-type current by GABAB 
receptors 
 
   In addition to PKC, Shen and Slaughter (1999) showed that the PKA inhibitor, 
Rp-cAMP (50 µM), was able to suppress L-type current facilitation by GABAB receptors 
in the salamander retina.  Therefore, two different PKA inhibitors, Rp-cAMPS and H-89, 
as well as a PKA activator, 8-Br-cAMP, were used to address the involvement of PKA in 
the signal transduction pathway of L-type calcium current facilitation by GABAB 
receptor activation in rat hippocampus.   
PKA is a tetrameric structure composed of two regulatory subunits and two 
catalytic subunits.  Inhibition of PKA can be achieved by either inactive cAMP analogues 
that competitively bind to the cAMP sites on the regulatory subunits or by compounds 
that block the ATP binding sites on the catalytic subunits.  The two PKA inhibitors used 
to investigate the involvement of PKA, were Rp-cAPMS and H-89.  Rp-cAMPS, is a 
cAMP analogue that has been shown to bind to both type I and type II regulatory subunits 
of PKA (Rothermel et al., 1984; Van Haastert et al., 1984; Rothermel and Botelho, 1988; 
Dostmann et al., 1990).  Binding of Rp-cAMPS to the cAMP sites prevents the 
dissociation of the catalytic subunits from the regulatory subunits.  Rp-cAMPS has also 
been shown to be resistant to cyclic nucleotide phosphodiesterases (Erneux et al., 1988).  
In comparison to Rp-cAMPS, H-89 does not prevent dissociation of the catalytic subunits 
from the regulatory subunits.  Rather, H-89 inhibits the action of PKA by binding to the 
ATP pocket on the catalytic subunits (Engh et al., 1996).  Since both Rp-cAMPS and H-
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89 are membrane permeable, these compounds were included in the external calcium 
solution and in the baclofen solution.   
In analyzing both of the PKA inhibitors together and comparing the distribution 
with the control cells, there is a significant difference in the distribution of the responses 
to baclofen in the absence and presence of PKA inhibitors (Figure 5.6; P = 0.011 using a 
Chi-square).  However, there were no significant differences in the percentage of cells 
demonstrating either inhibition or facilitation of sustained calcium current with 10 µM 
baclofen application when Rp-cAMPS was present (Figure 5.6).  In contrast to Rp-
cAMP, the percent cells demonstrating an inhibition or facilitation of sustained calcium 
current in responses to application of baclofen differed significantly in the presence of H-
89 (1 µM) in comparison to the control cells (Figure 5.6; decrease, P=0.032; increase, P = 
0.001 using a Fisher’s exact test for pairwise comparisons ).  H-89 blocked the ability  
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Figure 5.6: Effect of the PKA inhibitors, Rp-cAMPS and H-89, on the baclofen responses in 
hippocampal neurons.  The sustained component of calcium current was measured at the end of a 
300 msec depolarizing pulse to +10 mV from a holding potential of -80 mV.  Cells were 
classified as demonstrating a decrease (black bar), no change (light gray bar), or an increase (dark 
gray bar) in response to 10 µM baclofen.  Data were collected from 44 control cells, 26 cells in 
the presence of Rp-cAMP (30 µM, P = 0.239 using a Chi-square), and 28 cells in the presence of 
H-89 (1 µM, P = 0.005). Pairwise comparisons were done with a Fisher’s Exact Test.  * indicates 
a statistically significant difference. 
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  of baclofen to facilitate L-type calcium current, but baclofen was still able to facilitate 
sustained current in the presence of Rp-cAMPS.  Data using H-89 suggest that PKA is 
involved in the signal transduction pathway of L-type calcium current facilitation by 
GABAB receptors in the rat hippocampus, whereas data using Rp-cAMPS suggest that 
PKA is not involved in the signal transduction pathway of L-type calcium current 
facilitation by GABAB receptors in the rat hippocampus. 
 
8-Br-cAMP does not Modulate Calcium Currents in the Neonatal Rat Hippocampus 
 To determine whether PKA activation mimics the modulatory effects of baclofen, 
the cell-permeable cAMP analogue 8-Br-cAMP (500 µM) was used.  8-Br-cAMP was 
applied to the cells the same way baclofen was applied as described in Chapter 2.  The 
distribution of the responses differed when 8-Br-cAMP was applied to the cells (500 µM) 
in comparison to the control cells in which 10 µM baclofen was applied (Figure 5.7; P < 
0.001 using a Chi-square).  Most of the cells (91.7%) demonstrated no effect in response 
to 500 µM 8-Br-cAMP application, suggesting that PKA is not involved in the signal 
transduction mechanism of either the facilitation of L-type calcium current or an 
attenuation of N-type current by GABAB receptor activation.   
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Figure 5.7: Effect of the PKA activator 8-Br-cAMP on the baclofen responses in hippocampal 
neurons.  The sustained component of calcium current was measured at the end of a 300 msec 
depolarizing pulse to +10 mV from a holding potential of -80 mV.  Cells were classified as 
demonstrating a decrease (black bar), no change (light gray bar), or an increase (dark gray bar) in 
response to 10 µM baclofen or 500 µM 8-Br-cAMP.  Data were collected from 44 cells with 
baclofen and 24 cells with 8-Br-cAMP application (P < 0.001 using a Chi-square).  Pairwise 
comparisons were done with a Fisher’s Exact Test.  * indicates a statistically significant 
difference.   
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DISCUSSION 
 
The importance of calcium influx in neuronal function makes it a prime site for 
modulation by neurotransmitters and second messengers.  Many inhibitory interneuron 
subtypes within the hippocampus utilize GABA to regulate the overall excitability of the 
hippocampal region.  Our laboratory has demonstrated that activation of GABAB 
receptors can enhance calcium influx through L-type calcium channels and attenuate 
calcium influx through N-type calcium channels during development of the rat 
hippocampus (Carter and Mynlieff, 2004).  GABAB receptors are metabotropic and often 
regulate calcium or potassium channels through activation of G-proteins.  There are 
several mechanisms of calcium channel modification through both direct and indirect 
signaling pathways.  One of the most common signaling pathways associated with 
GABAB receptor activation is through Gi/o proteins (Morishita et al., 1990; Campbell et 
al., 1993; Menon-Johansson et al., 1993; Greif et al., 2000).  Both N-type and P/Q-type 
calcium current inhibition generally occurs through direct modulation by Gβγ subunits, 
which are sensitive to PTX suggesting the involvement of Gi/o proteins (Kleuss et al., 
1991; Herlitze et al., 1996; Ikeda et al., 1996; Furukawa et al., 1998; Zamponi and 
Snutch, 1998; Kajikawa et al., 2001; Mirshahi et al., 2002).  In the current study, 
treatment with PTX in hippocampal cultures isolated from 7 day old rats blocks the 
ability of baclofen to decrease calcium current, which has been shown to be through N-
type calcium channels (Carter and Mynlieff, 2004).  This is consistent with other studies 
that have demonstrated the involvement of Gi/o proteins in the attenuation of N-type 
calcium current by GABAB receptor activation in other regions of the rat brain, such as 
cerebellar granule neurons, cerebrocortical synaptosomes, supraoptic neurons, and 
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hippocampal pyramidal neurons (Amico et al., 1995; Santos et al., 1995; Harayama et al., 
1998; Bertrand et al., 2003).  The signal transduction mechanism of L-type calcium 
current facilitation by GABAB receptors in the rat hippocampus is not known.  
Facilitation of L-type calcium current by GABAB receptors was still seen in the presence 
of PTX, which suggests that Gi/o proteins are not involved in the signaling pathway of L-
type calcium current facilitation by GABAB receptors and that another mechanism must 
be involved.   
L-type calcium channels have several consensus sites for regulation by protein 
kinases.  Therefore, the involvement of both PKC and PKA in the pathway was 
investigated using several inhibitors and activators for each kinase.  Shen and Slaughter 
(1999) demonstrated that GABAB receptor activation can lead to the facilitation of L-type 
calcium current in a subset of salamander retinal neurons.  Approximately 43% of the 
cells they tested showed a facilitatory response to application of 500 nM baclofen.  In 
their study, the facilitation of L-type calcium current was blocked in the presence of the 
PKC inhibitors GF-109203X and PKC fragment 19-36.  In comparison to the PKC 
inhibitors, the PKA inhibitor Rp-cAMP only partially suppressed the facilitation of L-
type calcium current.  Their study suggested that PKC appears to be more important than 
PKA in the signaling pathway of GABAB receptor modulation of L-type current in the 
salamander retina (Shen and Slaughter, 1999).   
Our lab was the first to demonstrate the facilitation of L-type calcium current 
through GABAB receptor modulation in the mammalian CNS (Carter and Mynlieff, 
2004).  In the present study, we have demonstrated that PKC is involved in the pathway 
of L-type calcium current facilitation by GABAB receptors.  Several broad-spectrum PKC 
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inhibitors were used to verify the involvement of PKC in the pathway.  All three PKC 
inhibitors used, PKC fragment 19-36, GF-109203X, and chelerythrine chloride blocked 
the ability of baclofen to facilitate L-type calcium current in hippocampal cultures 
isolated from 6 to 8 day old rats.  These PKC inhibitors were chosen based on their 
specificity to several if not all of the PKC isoforms, their cell permeability, and their 
varying chemical structures.  To further confirm the involvement of PKC, a phorbol ester, 
PMA, was used to activate PKC and the responses to sustained calcium current were 
measured.  Facilitation was observed with PMA application in 30.80% of the cells, which 
is consistent with the 36.36% of cells that demonstrated facilitation with baclofen 
application.  All of these data suggest that PKC is involved in the signal transduction 
pathway of L-type calcium current facilitation by GABAB receptors in the neonatal rat 
hippocampus.   
Future experiments in the laboratory will explore the involvement of specific 
PKC isoforms in the pathway.  The fact that the facilitatory response is present in 
hippocampal cultures isolated from postnatal day 7, suggests that some of the PKC 
isoforms that are expressed later in development may not be involved.  The study by 
Roisin and Barbin (1997), which explored the presence of several PKC isoforms during 
hippocampal development, suggests that PKCγ is probably not involved in the signaling 
pathway.  PKCγ levels remain relatively low for the first postnatal week and only begin 
to rise following postnatal day 7 (Roisin and Barbin, 1997).  All of the other PKC 
isoforms tested, α, β, ε, and ζ were highly expressed by postnatal day 7.  Therefore, each 
of these isoforms could be involved in the pathway of GABAB receptor mediated 
facilitation of L-type calcium current.  Activation of PKC with PMA mimicked the 
 103
 
 
facilitation normally seen with baclofen application, which suggests that either 
conventional or novel PKC isoforms are involved in the pathway rather than the atypical 
isoforms.      
Facilitation was still seen in the presence of the PKA inhibitor, Rp-CAMP, but 
not when the PKA inhibitor H-89 was used.  The varying responses seen with the PKA 
inhibitors could be due to several reasons.  Rp-cAMPS and H-89 were chosen, because 
they are both membrane permeable inhibitors of PKA.  However, they inhibit PKA 
through two very different mechanisms.  Rp-cAMPS prevents the dissociation of the 
catalytic subunit from the regulatory subunit by competitively binding to the cAMP sites 
on the regulatory subunit.  This inhibitor blocks the activation of the catalytic subunit all 
together and thus dissociation from the regulatory site.  In comparison, H-89 associates 
with the ATP binding site on the catalytic subunit and blocks the phosphorylation 
processes of PKA.  Even though H-89 is a potent inhibitor for PKA (Chijiwa et al., 
1990), it has been shown to inhibit several other kinases including p70 ribosomal protein 
S6 kinase 1 (S6K1; IC50 = 80 nM), mitogen- and stress-activated protein kinase (MSK1; 
IC50 = 120 nM), PKG (IC50 = 340 nM), CaMKII (IC50 = 11 µM), and PKC (IC50 = 14 
µM; Davies et al., 2000, for review see Lochner and Moolman, 2006).  Thus, it is 
possible that H-89 is inhibiting other kinases, which is causing variation in the calcium 
current responses seen to baclofen application when compared to the other PKA inhibitor 
used.  Direct activation of PKA with 8-Br-cAMP did not result in the facilitation of L-
type calcium current, which suggests that PKA is not involved in the signal transduction 
pathway of L-type calcium current by GABAB receptor activation.   
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In conclusion, during the early neonatal period in the rat hippocampus GABAB 
receptor activation can lead to the attenuation of N-type calcium current and the 
facilitation of L-type calcium current.  The current study has demonstrated that the 
attenuation of N-type calcium current by GABAB receptor activation is mediated through 
a PTX sensitive G-protein pathway.  Attenuation of N-type calcium current was still 
observed in the presence of PKC and PKA inhibitors and attenuation of N-type calcium 
current was not seen with direct activation of PKC and PKA.  These experiments suggest 
that neither PKC nor PKA are involved in the pathway of N-type calcium current 
modulation by GABAB receptors.  Facilitation of L-type calcium current was still 
observed in the presence of PTX, which demonstrated that Gi/o proteins were not 
involved in the pathway.  Facilitation of L-type calcium current was not seen in the 
presence of PKC inhibitors and facilitation was observed with direct activation of PKC 
with a phorbol ester.  These experiments suggest that PKC is involved in the pathway of 
L-type calcium current facilitation by GABAB receptor activation in the rat hippocampus.  
Facilitation was still observed in the presence of Rp-cAMP, but not in the presence of 
another PKA inhibitor H-89.  Direct activation of PKA with a cAMP analogue, 8-Br-
cAMP, did not result in the facilitation of L-type calcium current.  Therefore, the results 
using Rp-cAMP and 8-Br-cAMP suggest that PKA is not involved in the signal 
transduction pathway of L-type calcium current facilitation by GABAB receptors.   
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CHAPTER 6 
GENERAL DISCUSSION 
 The primary findings presented in these studies demonstrate that the facilitation of 
L-type calcium current by GABAB receptor activation is more prominent in the second 
postnatal week when compared to the first postnatal week of hippocampal development 
in the rat.  In comparison, the inhibition of N-type calcium current was found to be more 
prominent during the first postnatal week when compared to the second postnatal week of 
hippocampal development.  The facilitation of L-type calcium current was blocked in the 
presence of PKC inhibitors and the response was mimicked with direct activation of PKC 
with a phorbol ester.  Time course studies using Western blot analysis demonstrated that 
KCC2 protein levels increase during the first two postnatal weeks, while NKCC1 protein 
levels remain relatively level in both hippocampal cultures and whole hippocampal 
protein extracts of rat pups.  Calcium influx through L-type calcium channels was shown 
to be necessary at least in part for the upregulation of KCC2 protein levels.   
 The hippocampus contains excitatory pyramidal neurons and over 21 different 
types of inhibitory interneurons.  Approximately 30% of the cells in hippocampal 
cultures isolated from pups 7 to 14 days old demonstrate facilitation of L-type calcium 
current.  Due to the heterogeneity of hippocampal cell cultures, it is possible the 
facilitatory response of calcium current by GABAB receptors is only observed in a 
particular subset of cells.  A study by Nuñez and McCarthy (2007), demonstrated peak 
protein levels of the L-type calcium channel subtype Cav1.2 in hippocampal protein 
extracts isolated from 7 day old rat pups.  Previous immunocytochemical experiments in 
the Mynlieff laboratory have demonstrated that only about 30% of the neurons in our 
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cultures express Cav1.2, whereas almost all of the neurons express Cav1.3.  Preliminary 
data using Western blot analysis of membrane proteins isolated from the superior region 
of hippocampi from rats of varying ages demonstrate that Cav1.2 levels are high in the 
first postnatal week, whereas Cav1.3 protein levels begin low and increase throughout 
neonatal development (Ingraham, unpublished data).  The early expression of Cav1.2 and 
its restriction to a subset of cells suggest that Cav1.2 rather than Cav1.3 is involved in the 
facilitatory response of calcium current by GABAB receptors. 
The data presented indicate that PKC is involved in the signaling pathway of L-
type calcium current facilitation by GABAB receptors.  Furthermore, this effect is likely 
to be mediated by a conventional or novel isoform of PKC rather than an atypical form 
since the effect of baclofen on L-type current was mimicked by the PKC activator, PMA.  
However, PKC may not directly phosphorylate L-type calcium channels to produce this 
response.  Rather than direct phosphorylation of the calcium channel, PKC may 
phosphorylate another intermediate effector protein.  For example, the enhancement of L-
type calcium current has been observed in isolated rat ventricular myocytes by activation 
of α1A adrenoceptors.  This enhancement of L-type calcium current was mediated through 
a PKC and CaMKII pathway (O-Uchi et al., 2005, 2008).  Several other studies in cardiac 
and smooth muscle myocytes have suggested that CaMKII is involved in a calcium-
dependent facilitation of L-type calcium current (McCarron et al., 1992; Anderson et al., 
1994; Yuan and Bers, 1994). Thus, it is possible that PKC may phosphorylate and 
activate CaMKII to facilitate L-type calcium current in the rat hippocampus (Figure 6.1).  
Additional studies in the laboratory will utilize CaMKII inhibitors, to investigate the 
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involvement of the kinase in the pathway of L-type calcium current facilitation by 
GABAB receptors.   
 
Figure 6.1:  Possible signal transduction pathway of L-type calcium current 
facilitation by GABAB receptors. Abbreviations:  PIP2, phosphoinositol 
bisphosphate; PLC, phospholipase C; DAG, diacylglycerol; PKC, protein kinase 
C; IP3, inositol trisphosphate; CaMKII, calcium/calmodulin dependent kinase II. 
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cell types, including skeletal muscle, cardiac muscle, smooth muscle, neurons, and 
adrenal chromaffin cells.  The enhancement of L-type calcium current increases the force 
of contraction during tetanic stimulation in skeletal muscle (Schmid et al., 1985; Arreloa 
et al., 1987; Sculptoreanu et al., 1993a) and also increases the force of contraction in 
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et al., 1992).  These are just a few examples of the importance L-type calcium current 
facilitation plays in many native cell types.   
 Calcium influx through VDCCs and NMDA receptors is crucial in developing 
neurons.  Calcium signaling is involved in the proliferation, migration, and differentiation 
of neurons (Marty et al., 1996).  Calcium influx also plays an important role in 
synaptogenesis and the integration of new synapses into neuronal networks (Eins et al., 
1983; Kneussel and Betz, 2000).  An increase in gene expression and DNA synthesis is 
also observed as a result of the increase in calcium levels (West et al., 2001).  It is 
possible that the enhancement of L-type calcium current in response to GABAB receptor 
activation could be playing a very specific and important role in one of these responses, 
such as signaling changes in gene expression.  The occurrence of L-type calcium current 
facilitation in the early neonatal period suggests that calcium influx plays a functional 
role in the maturation process of hippocampal neurons.   
 GABA is the main inhibitory neurotransmitter in mature neurons, but its effects 
are excitatory in immature neurons.  The excitatory actions of GABA during 
development have been demonstrated in several brain regions, including the 
hippocampus (Mueller et al., 1984; Ben-Ari et al., 1989; Cherubini et al., 1990; 
Leinekugel et al., 1995; Khazipov et al., 1997; Ganguly et al., 2001), cerebellum ( Eilers 
et al., 2001), neocortex (Luhmann and Prince, 1991; Yuste and Katz, 1991; Fukuda et al., 
1998; Owens et al., 1999), and the hypothalamus (Chen et al., 1996; Obrietan and Van 
Den Pol, 1999; Gao and Van Den Pol, 2001).   Interestingly, GABA and glycine exert 
excitatory actions in the developing spinal cord as well (Serafini et al., 1995; Wang et al., 
1994; Vinay and Clarac, 1999).  The excitatory response of GABA during development 
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plays a critical role in the proliferation, migration, and differentiation of neurons and also 
in the formation of synapses (for review see Ben-Ari, 2002; Owens, 2002).   
 The excitatory actions of GABA depend on the location, type, and developmental 
stage of the neuron.  The switch from excitatory-to-inhibitory may occur at different 
developmental stages in the various brain regions and even occur at different stages for 
the various cell types found within a single region.  For example, in the hippocampus it is 
suggested that the excitatory-to-inhibitory switch occurs in inhibitory interneurons before 
pyramidal cells.  Studies by Hennou and colleagues (2002) have demonstrated the 
sequential development of GABAergic and then glutamatergic synapse formation in CA1 
hippocampal interneurons in rats.  It is possible that the GABAergic switch even within 
different groups of interneurons can occur at different developmental stages (Hennou et 
al., 2002).  Similarly, GABA synapses precede the formation of glutamatergic synapses 
in rat hippocampal CA1 pyramidal neurons (Tyzio et al., 1999).  In patch clamp 
recordings from hippocampal slices isolated from postnatal day 0 rats, three different 
populations of CA1 pyramidal cells were observed (Tyzio et al., 1999).  There are 
pyramidal cells that have functional GABAA and glutamate receptors, but are silent and 
do not exhibit excitatory postsynaptic currents (PSCs).  There are cells that just exhibit 
GABA mediated excitatory PSCs, while the last group of cells exhibits both GABA and 
glutamate mediated excitatory PSCs.  The group of cells that exhibit both GABA and 
glutamate PSCs are more developed than the other two groups and contain both an apical 
and basal dendrite (Tyzio et al., 1999; for review see Ben-Ari, 2002).  The fact that 
GABAergic synapses are formed on interneurons prior to pyramidal cells, suggests that 
the excitatory actions of GABA and subsequent influx of calcium may play an important 
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role in the maturation of interneurons, which subsequently aids in the maturation of 
pyramidal neurons.    
 In immature neurons, GABAA receptor activation can depolarize the membrane 
and increase intracellular calcium levels through activation of L-type calcium channels 
(Yuste and Katz, 1991; Leinekugel et al., 1995; Ganguly et al., 2001).  Long lasting 
depolarizing potentials called giant depolarizing potentials (GDPs) are also observed 
during the first two postnatal weeks in rat hippocampal interneurons and CA3 and CA1 
pyramidal neurons and are only present when GABA is excitatory (Ben-Ari et al., 1989; 
Leinekugel et al., 1995, 1997, 1998; Khazipov et al., 1997).  Glutamatergic synapses also 
contribute to GDPs with the activation of NMDA receptors, which further increase 
calcium levels in immature neurons.  These large oscillations of intracellular calcium 
levels aid in neuronal growth and synapse formation (for review see Ben-Ari, 2002; 
Owens and Kriegstein, 2002).  Inhibition by GABAB receptors plays an important role in 
controlling the duration of the GDPs (Mclean et al., 1996; Caillard et al., 1998).  
 Whether or not GABA exerts an excitatory response early in development is 
largely dependent on the reversal potential for chloride.  In mature neurons, intracellular 
chloride levels are relatively low.  Therefore, GABAA receptor activation results in 
chloride influx and hyperpolarizes the neuron.  In immature neurons, intracellular 
chloride levels are higher than in mature neurons.  GABAA receptor activation in an 
immature neuron results in chloride efflux and depolarizes the neuron.  It is thought that 
the changes in the intracellular chloride levels are mediated by developmental changes in 
the expression of the specific chloride cotransporters, NKCC1 and KCC2.  NKCC1 
predominates in the early neonatal period and mediates chloride influx, while KCC2 
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expression predominates in mature neurons and mediates chloride efflux.  KCC2 protein 
levels increase during the first two postnatal weeks, while NKCC1 protein levels remain 
relatively level in both hippocampal cultures and whole hippocampal protein extracts of 
rat pups.  NKCC1 expression is critical during the early neonatal period, however 
because protein levels remain level throughout the first two weeks of development this 
cotransporter does not appear to be solely responsible for the GABAergic switch.  Our 
study was the first to compare the protein levels of both NKCC1 and KCC2 throughout 
hippocampal development to determine a ratio of the two transporters.  Rather than the 
upregualtion of KCC2 and the downregualtion of NKCC1 protein, the data presented 
here suggest that it is the ratio of KCC2 to NKCC1 that is important for the 
developmental switch of the GABAA response. 
 One of the biggest questions in the developmental regulation of the reversal 
potential for chloride is what signals are involved in the increase in KCC2 expression 
during the early neonatal period.  Do the excitatory actions of GABA itself trigger the 
cascade through the increase of intracellular calcium levels?  Ganguly et al., (2001) 
demonstrated that calcium influx is necessary for the excitatory-to-inhibitory switch of 
GABAA receptors during the early postnatal period.  In addition, they observed a 
decrease in KCC2 mRNA with the blockade of GABAA receptors (Ganguly et al., 2001).  
The current study has demonstrated that calcium influx through L-type calcium channels 
is necessary for the upregulation of KCC2 protein levels.  Inhibition of L-type calcium 
channels with nimodipine blocked the upregulation of KCC2 protein levels in 
hippocampal cultures by 50%.  Together, these studies demonstrate that GABAA 
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excitation and calcium influx through L-type calcium channels is necessary for the 
upregulation of KCC2 and the subsequent switch in the GABAergic response.   
 Increases in the phosphorylated form of the transcription factor, cAMP response 
element-binding protein (pCREB), are observed with GABAA receptor activation during 
the first postnatal week and this effect is blocked by L-type calcium channel antagonists 
(Perrot-Sinal et al., 2003; Mantelas et al., 2007; Nuñez and McCarthy, 2007).  GABA 
induced increases in intracellular calcium levels, which activate pCREB, can induce 
BDNF expression (Berninger et al., 1995; Obrietan et al., 2001; West et al., 2001).  
BDNF levels are higher in the first two postnatal weeks of development and BDNF may 
play an important role in the maturation of the GABAergic system.  It has been 
demonstrated that overexpression of BDNF can increase the amount of GABAergic 
synapses early in development and also increase KCC2 mRNA levels in transgenic 
embryos (Aguado et al., 2003).  Interneurons do not express BDNF.  Therefore, it is 
possible that the release of BDNF from pyramidal cells aids in the upregulation of KCC2 
in interneurons.  Therefore, BDNF could either increase KCC2 levels in the neuron 
expressing it or bind to BDNF receptors (trkB) on neighboring interneurons that would 
lead to an increase of KCC2 expression in these cells.  In addition to activation of 
transcription factors and neurotrophins, L-type calcium current has also been shown to 
activate kinases such as CaMKII, which could be involved in the phosphorylation of 
CREB and the increase in BDNF expression (West et al., 2001).  Thus, it is possible that 
activation of neurotrophins, transcription factors, and kinases by calcium influx through 
L-type calcium channels could all be involved in gene activation and trigger the 
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upregualtion of KCC2 during the early neonatal period in either pyramidal neurons or 
interneurons in the hippocampus (Figure 6.2).   
 The increase in calcium current is also involved in membrane trafficking and 
posttranslational changes in addition to changes in gene transcription and protein 
synthesis.  In a study by Fiumelli et al., (2005), the shift in the chloride reversal potential 
was not observed in the presence of Ca2+-dependent PKC inhibitors.  Direct 
phosphorylation of KCC2 by PKC decreases endocytosis of KCC2 proteins, thus 
enhancing KCC2 protein levels in the membrane (~200% increase, Lee et al., 2007).  
Therefore, it is possible that activation of PKC by L-type calcium current could be 
regulating membrane trafficking of the KCC2 transporter (Figure 6.2).    
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Figure 6.2: Possible signaling events involved in the upregualtion of KCC2.  GABA mediated 
increases in L-type calcium current could activate a signaling cascade involving several steps 
resulting in the upregualtion of KCC2.  In addition, activation of PKC by L-type calcium current 
can decrease endocytosis thereby decreasing the degradation of KCC2 protein in these neurons.   
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 There are still many questions to be answered regarding the signal transduction 
mechanism of L-type calcium current facilitation by GABAB receptors during the early 
neonatal period in the rat hippocampus.   Since PKC is involved in the mechanism of L-
type current facilitation it is possible that GABAB receptors are coupled to Gαq/11 and 
PLC in a subset of neurons in the neonatal rat hippocampus.  Inhibitors of PLC and the 
selective Gαq/11 inhibitor (YM-254890) could be used to investigate the coupling of 
GABAB receptors to Gαq/11 and PLC in neonatal rat hippocampal cultures using 
electrophysiological recording or calcium imaging.  The association of GABAB receptors 
with Gαq/11 would be a novel finding, because GABAB receptors predominantly couple to 
Gαi/o proteins (Morishita et al., 1990; Campbell et al., 1993; Menon-Johansson et al., 
1993; Greif et al., 2000).   
 Future experimentation could also investigate the involvement of CaMKII in the 
pathway of L-type calcium current facilitation in the rat hippocampus, since the 
enhancement of calcium influx through Cav1.2 channels in cardiac myocytes has been 
shown to be mediated through a PKC / CaMKII pathway.  To determine whether 
CaMKII is involved in the signal transduction pathway of L-type calcium current 
facilitation by GABAB receptors, whole-cell patch clamp recording and calcium imaging 
in hippocampal neurons could be performed in the presence of CaMKII inhibitors.  If 
facilitation by GABAB receptors was no longer observed in the presence of CaMKII 
inhibitors, it would suggest that CaMKII is involved in the facilitatory pathway along 
with PKC.    
 In addition, the specific PKC isoforms involved in the signaling mechanism have 
not been identified.  Since the atypical PKC isoforms do not have a DAG binding site and 
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are not activated by phorbol esters, it is highly unlikely that they are involved in the 
facilitation of L-type calcium channels by GABAB receptors in this subset of cells.  The 
involvement of conventional and novel PKC isoforms in the pathway could be 
investigated using similar electrophysiological experiments that were performed with the 
general PKC inhibitors presented here, but rather with specific inhibitors of the different 
PKC isoforms.  Calcium imaging, which provides much faster data acquisition than 
electrophysiological recording, could also be used to test the effects of kinase inhibition 
on the baclofen responses seen in hippocampal cultures.  In addition, Western blot 
analysis using antibodies against the phosphorylated states of specific PKC isoforms with 
baclofen treatment could also be used to investigate the PKC isoform involved.  Further 
studies using Western blot analysis could also be used to determine the translocation of 
the conventional and novel PKC isoforms to the membrane with baclofen treatment.   
 Several studies have suggested that the Cav1.2 rather than the Cav1.3 L-type 
calcium channel is facilitated by GABAB receptor activation in neonatal rat hippocampus.  
Through immunohistochemical experiments and confocal micrscopy in hippocampal 
slices, it could be determined if Cav1.2 L-type calcium channels colocalize with GABAB 
receptors, and specifically which subtype of the GABAB receptor is involved: GABAB1a 
which is located presynaptically or GABAB1b which is primarily located postsynaptically 
(Vigot et al., 2006).  The developmental changes of L-type channels and GABAB 
receptor expression could also be observed through immunohistochemical analysis.  
Using a Zeiss Pascal confocal microscope equipped with two laser lines and 
fluorescence, the specific subcellular localization of antibody staining could be 
thoroughly analyzed.  Since L-type current facilitation by GABAB receptor activation is a 
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developmental phenomenon that predominates during the second postnatal week, it is 
likely that L-type calcium channels may only be colocalized with GABAB receptors early 
in neonatal development and not in adult rats.  Further confirmation of the involvement 
of Cav1.2 could involve electrophysiological recording in hippocampal cultures in the 
absence of Cav1.2 channels.  Short hairpin RNA knockdown of the Cav1.2 α1 subunit in 
dorsal horn neurons has been shown to effectively decrease expression of the channel in 
the membrane (Fossat et al., 2010).  If the Cav1.2 gene is effectively silenced, GABAB 
receptors would no longer be able to facilitate L-type calcium current in hippocampal 
neurons.   
 Using hippocampal slices, it could be possible to identify the subset of cells in 
which L-type calcium channels and GABAB receptors are colocalized.  Inhibitory 
interneurons within the hippocampus are highly diverse, but different types of 
interneurons can be identified based on morphology.  Somatic location within a layer as 
well as dendritic shape can aid in the identification of an interneuron class.  Molecular 
cell markers such as calcium binding protein, parvalbumin, cholecystokinin, and 
vesicular glutamate transporter 3 can also be used to identify interneuron classes 
(Somogyi and Klausberger, 2005; Klausberger and Somogyi, 2008).  However, a single 
molecular marker, such as parvalbumin, could not be used to identify an interneuron class 
on its own, because many of the interneuron classes can express the same molecular 
markers.  Therefore, both morphological characteristics and antibody labeling would 
have to be utilized to determine if and which specific class of interneurons GABAB 
receptors colocalize with L-type calcium channels.  A single hippocampal slice could be 
labeled with antibodies against GABAB receptors, Cav1.2 L-type calcium channels, and 
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an interneuron marker to distinguish which subset of cells GABAB receptors and L-type 
calcium channels are colocalized.  It would be interesting to determine the specific subset 
of cells where GABAB receptors and L-type calcium channels are colocalized, because it 
could provide further indications as to the functional significance of L-type calcium 
current facilitation by GABAB receptors during development.  It is possible that the class 
of cells in which GABAB receptors and L-type calcium channels are colocalized may be 
specifically important in the time course of the maturation of interneurons and pyramidal 
cells.   
 Together, the experiments presented here along with the proposed experiments 
would further our knowledge of the molecular mechanisms that control excitatory and 
inhibitory synapse maturation in the developing rat hippocampus.   
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